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ABSTRACT 
Morphogenesis, or the development of tissues, structures, and organs, is at the 
heart of embryonic development. Morphogenesis is a complex, multi-tissue process that 
requires coordinated cellular communication, migration, and differentiation; due to this 
complexity, the mechanisms that underlie morphogenesis remain poorly understood. The 
sea urchin embryo is morphologically and genetically more simple than most other 
developmental model organisms, and is optically transparent, making it a highly tractable 
system in which to study morphogenetic processes. The sea urchin larval endoskeleton is 
a biomineral that is secreted by primary mesenchyme cells (PMCs). The PMCs ingress 
into the embryo and remain individual, mesenchymal cells that migrate into a stereotypic 
three-dimensional (3-D) pattern within the blastocoel, prefiguring the form of the ensuing 
skeleton, which they subsequently secrete. PMC positioning is directed by cues 
originating in the overlying ectoderm; however, the molecular identity of those cues has 
remained unknown. The work described in this dissertation combines systems-level 
approaches with in vivo 3-D spatial analysis to identify novel skeletal patterning genes 
and to define their functional roles in skeletal patterning.  A transcriptomics-based screen 
identified numerous novel candidate skeletal patterning cues. Of those cues, two were 
	
	 vii 
further pursued for detailed functional studies. First, the sulfate transporter SLC26a2/7 
(SLC) was found to promote ventral accumulation of sulfated proteoglycans that is both 
necessary and sufficient to attract PMCs to the ventral territory for ventral skeleton 
formation. Second, the enzyme 5-lipoxygenase (LOX) was found to be required for 
ventral and rotational skeletal patterning, and its product, 5(S)-HETE was found to be a 
chemoattractant for PMCs, thereby identifying a novel role for lipoxygenase enzymes in 
embryonic patterning and morphogenesis. Recent work from other groups has 
demonstrated that PMCs diversify their gene expression profiles during skeletal 
patterning, implying that PMC diversification is involved in skeletal patterning, likely as 
a response to locally distinct spatial cues. The studies herein identify Tbx2/3 and Pks2 as 
important PMC subset-specific genes whose spatial expression is modulated by SLC and 
LOX, respectively. Together, these results provide new mechanistic insights that define 
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1.1 Abstract  
Tissue patterning during embryonic development drives the formation of complex 
three-dimensional shapes in biological organisms, and many important facets of tissue 
patterning remain open questions in developmental biology. The sea urchin embryo 
provides a convenient model to study tissue patterning, in which a population of 
migratory mesenchyme cells secretes a simple, rigid endoskeleton. The primary 
mesenchyme cells (PMCs) receive patterning instructions from the overlying ectoderm 
and arrange into a distinct three-dimensional shape. While this ectoderm-mesoderm 
relationship was proposed nearly a century ago, the ectodermal cues and the subsequent 
mechanisms underlying the dynamics of PMC positioning are only recently being 
identified. Recent studies have unearthed a number of ectodermal factors that contribute 
to skeletogenesis, but many of these are required for biomineralization, or broadly disrupt 
PMC positioning. Here we review the contributions of known cues to skeletogenesis and 
PMC patterning, and attempt to distinguish between signals that regulate 
biomineralization and PMC positioning. We will further discuss the identification of 
novel ectodermal cues from an RNA-Seq based screen, and their contributions to discrete 
aspects of PMC patterning and skeletal morphogenesis. 
1.2 Introduction 
Morphogenesis during development involves the hierarchical deployment of 




differentiation. These diverse cellular conversations are exceedingly difficult to untangle, 
often requiring a combination of systems-level and in vivo approaches. The sea urchin, as 
a basal deuterostome, provides a genetically and morphologically simple platform to 
study morphogenetic events, with relevance to developmental processes in higher order 
vertebrates. Specifically, the sea urchin larval endoskeleton and the mesenchymal cells 
that secrete it are highly amenable to experimental perturbation and offer a useful visual 
readout of embryonic patterning decisions. Here, we discuss historical perspectives and 
recent developments in the understanding of the molecular basis of sea urchin skeletal 
morphogenesis. 
1.2.1 Sea urchins as a model for tissue patterning 
The sea urchin has been a popular developmental model organism for over a 
century, and as a result, embryonic development of the sea urchin is well-documented 
process (Fig.1 1.1). The sea urchin embryo and larva are optically transparent, easing the 
study of their internal processes and use of fluorescent probes. The genomes and 
transcriptomes of three sea urchin species have been sequenced, providing a useful 
database for gene discovery. Sea urchin embryos develop rapidly, and can be 
synchronously cultured at large scale, making them ideal for systems-level studies that 
require large samples. The species used in this study, Lytechinus variegatus, develops to 
a pluteus larva with a well-formed skeleton in 48 hours at room temperature (Hogan et 
al., 2020). As a basal, nonchordate deuterostome, the sea urchin is a valuable model 
system to inform studies in chordate and vertebrate deuterostomes including humans. 




transcriptional diversity that is comparable to vertebrates and humans. However, since 
sea urchins did not undergo whole genome duplication events in their evolutionary past, 
they lack the genetic redundancy and concomitant complexity of other vertebrate 
organisms, including humans (Beane et al., 2006; Bradham et al., 2006; Byrum et al., 
2006; Croce et al., 2006; Goldstone et al., 2006; Lapraz et al., 2006; Sea Urchin Genome 
Sequencing et al., 2006; Ettensohn et al., 2007). Because of its unexpectedly high 
transcriptomic similarly to humans and other vertebrates, uncovering the mechanisms 
that regulate morphogenesis in sea urchin embryos is very likely to inform the 
considerably more complex development and morphogenesis of humans and other 
vertebrate embryos. 
 At the larval stage, the sea urchin contains approximately 2000 cells of an 
estimated 15 different types (Angerer et al., 2000). Early cell divisions have been fate-
mapped, and gene regulatory network models have been defined that govern the 
specification all three germ layers up to gastrulation (the internalization of endodermal 
and mesodermal cell types) (Cameron et al., 1991; Davidson et al., 2002a; Davidson et 
al., 2003; Oliveri et al., 2003; Su et al., 2009b; Saudemont et al., 2010a). The relative 
genetic and morphological simplicity of the sea urchin, its extensive historical 
background as a developmental model, the network-level understanding of its early 
specification, and its amenability to large-scale chemical perturbations and systems-level 
analyses make it a highly tractable platform for experimentally assessing tissue patterning 
mechanisms. 




Secretion of the larval endoskeleton is a fascinating and well-studied topic in sea 
urchin development. The first three cleavages of the sea urchin zygote are symmetric, and 
result in an 8-cell stage embryo with 4 anterior and 4 posterior cells. At the 16-cell stage, 
the posterior cells ("vegetal") undergo an asymmetric cleavage, yielding four large 
anterior daughter cells, and a four small posterior daughter cells known as micromeres. 
The micromeres again cleave asymmetrically, yielding four large anterior and four small 
posterior micromeres at the 32-cell stage. The small micromeres give rise to the germ 
line, while the large micromeres are specified as mesoderm, and are the precursors to the 
skeletogenic cells. The large micromeres nuclearize ß catenin, a transcriptional co-
activator; after the following cleavage, nuclearized b-catenin induces the expression of 
the paired homeodomain protein pmar1.  Pmar1 is a master regulator of the skeletogenic 
fate. It functions by releasing repression of the specification gene-regulatory network for 
this lineage, giving rise to skeletogenic primary mesenchyme cells (PMCs) (Oliveri et al., 
2002; Oliveri et al., 2003). After further development, the approximately 32 large 
micromere daughters undergo an epithelial-to-mesenchymal transition (EMT), invade 
through from the basal lamina, and individually ingress into the blastocoel as PMCs (Wu 
et al., 2007; Saunders and McClay, 2014). Following ingression, the cells then divide 
once more, giving rise to about 64 PMCs (Ettensohn, 1990). PMCs migrate freely as 
individuals within the blastocoel, extending thin filopodia that contact the overly 
ectoderm and other PMCs (Malinda et al., 1995; Miller et al., 1995). Within two to three 
hours, they reliably arrange into a stereotypic three-dimensional (3-D) pattern, composed 




chains of cells, and additional chains that extend anteriorly from the clusters (von Ubisch, 
1937; Okazaki, 1965; Gustafson and Wolpert, 1999). This initial, "primary" pattern of the 
PMCs dictates the primary skeletal pattern, which these cells produce via secretion of 
biomineral. While some molecules that generally or specifically govern PMC migration 
have been identified, including extracellular matrix (ECM) components EMC3 (Hodor et 
al., 2000) and fibronectin (Katow et al., 1990), as well as growth and transcription factors 
from the ectoderm (Duloquin et al., 2007; Rottinger et al., 2008; Cavalieri et al., 2011; 
McIntyre et al., 2013b; Piacentino et al., 2015a), the mechanisms regulating specific 
aspects of this migration pattern are largely unknown, and are a primary focus of this 
dissertation.  
As PMCs migrate, they produce protrusions that undergo fusion with similar protrusions 
on adjacent PMCs, forming a continuous syncytial cable. This cable wraps around a 
membrane-delimited lumenal space into which calcium carbonate biomineral is secreted 
(Okazaki, 1965; Livingston et al., 2006; Killian and Wilt, 2008; Wilt et al., 2013a). 
Biomineralization begins in a syncytial lumenal space, which is positioned between the 
ventrolateral cluster PMC cell bodies and the overlying ectoderm. Bilateral spicule 
rudiments form first, laying groundwork for the skeletal triradiates, which are three-
pronged structures that align with the ventral, dorsal, and anterior PMC chains (Guss and 
Ettensohn, 1997; Killian and Wilt, 2008). The triradiates then undergo a series of 
branching and elongation events over the next 24 hours, eventually giving rise to the 
larval endoskeleton. 




The pluteus skeleton is a bilaterally symmetric arrangement of calcium carbonate 
rods, with eight distinct elements per skeletal half – making it complex enough to have a 
unique profile along each embryonic axis, but simple enough to permit the experimental 
differentiation of the effects of subtle, local regulatory events that govern its 
morphogenesis. The study of skeletal patterning in the sea urchin embryo provides 
valuable insight into the relationship between spatial signals and 3-D morphogenesis, as 
the skeleton-secreting PMCs are actively positioned by positional cues in the overlying 
ectoderm – an idea first proposed by von Ubisch in 1937. His study noted that PMCs 
extend thin filopodia that contact and appear to probe the ectoderm, suggesting that 
filopodia may act as conduits to convey skeletal patterning information from the 
ectoderm to the PMCs (von Ubisch, 1937). This hypothesis was later supported by 
elegant studies in which PMCs transplanted into a chemically-treated ectodermal hull 
produced defective skeletons, while chemically-treated PMCs transplanted into an 
untreated hull produced normal skeletons (Armstrong et al., 1993). In addition to 
providing patterning cues, photoablation of ectodermal cells blocks local biomineral 
deposition (Malinda and Ettensohn, 1994), indicating that the ectoderm provides acute, 
local instructions for PMCs to build the skeleton. This hypothesis was experimentally 
tested by generating interspecies PMC-ectoderm chimeras, in which PMCs from two 
species of sea urchin, Lytechinus variegatus and Tripneustes vertricosus, were 
transplanted into the ectodermal hull of the other. Tripneustes larvae form a more 




from the main skeletal rods (Armstrong and McClay, 1994), and transplanted PMCs were 
able to synthesize these elements. 
 More recently, the VEGF and FGF pathways have been implicated in PMC 
migration. While VEGF expression is spatially restricted in the ectoderm, its cognate 
receptor is expressed in all PMCs (Duloquin et al., 2007). FGF expression, on the other 
hand, is spatially restricted within both the ectoderm and the PMC population to locations 
undergoing or adjacent to active biomineralization, but appears to be dispensable for 
PMC positioning in Lytechinus variegatus (Adomako-Ankomah and Ettensohn, 2013a). 
A number of other transcription factors and signaling ligands, including Otp (Di 
Bernardo et al., 1999), strim1 (Cavalieri et al., 2011), Pax2/5/8 (Rottinger et al., 2008), 
and Wnt5a (McIntyre et al., 2013b) are expressed in similar ectodermal territories to 
VEGF and FGF. Loss of function of each of these genes results in a global block to 
skeletogenesis, suggesting that they participate in a master regulatory circuit that governs 
biomineralization in all PMCs. 
1.2.4 Gene expression within PMCs 
The PMCs have long been thought to be a homogenous population of cells, 
directed to their spatial positions exclusively by migratory cues in the overlying 
ectoderm. Indeed, when they first ingress into the blastocoel, PMCs are considered to be 
homogeneous (Davidson et al., 2002b; Oliveri et al., 2002; Oliveri et al., 2003). 
Interestingly, following ingression, PMCs diversify as they migrate, adopting differing 
gene expression profiles that reflect their spatiotemporal context within the embryo (Fig 




differentially respond to the presented ectodermal cues to form a complex 3-D shape. The 
first evidence of heterogeneity within the PMC population was the localization of t-box 
transcription factor, Tbx2/3, to the dorsal hemisphere of all three germ layers, including 
PMCs (Croce et al., 2003a; Gross et al., 2003).   
Recent efforts to classify the spatial patterns of PMC effector genes have 
uncovered a large cohort of non-uniformly-expressed mRNAs, and showed that gene 
expression within the PMCs depends on extrinsic, ectodermal cues (Sun and Ettensohn, 
2014). This set of PMC subset-specific genes includes biomineralization-related genes, 
occluded biomineral proteins, adhesion-related genes, transcription factors, and a number 
of genes with unknown function (Rafiq et al., 2012; Sun and Ettensohn, 2014).  While the 
expression patterns of these genes are highly variable, many are elevated at sites of active 
biomineralization, and the expression of some is dependent on VEGF signaling, which is 
concentrated at sites of active biomineralization (Sun and Ettensohn, 2014). Importantly, 
so far, none of these PMC-specific genes have been implicated in regulating specific 
aspects of PMC migration or patterning. Here, using FISH and single-cell RNA 
sequencing, we define the impact of perturbing ectodermal cues on the expression of 
several PMC subset-specific genes and define the functional importance of one of these 
genes for PMC positioning. 
1.3 Thesis rationale 
Ectodermal genes that have been implicated in sea urchin skeletogenesis may 
have numerous roles in regulating this multi-faceted process. Because biomineralization 




patterning genes are difficult to parse. Indeed, most of the genes described thus far are 
broad regulators of biomineralization and PMC positioning, whereby knockdown or 
inhibition experiments result in a complete loss of both biomineralization and a 
recognizable PMC pattern (Cavalieri et al., 2003a; Duloquin et al., 2007; Rottinger et al., 
2008; Cavalieri et al., 2011; McIntyre et al., 2013b). Importantly, no cues thus far, with 
the exception of univin (Piacentino et al., 2015a), regulate specific aspects of PMC 
positioning or skeleton pattern formation. Here, we utilize an RNA-Seq-based screen to 
identify novel skeletal patterning candidates, combined with 3-D spatial analysis of PMC 
positioning and gene expression to determine the roles of our novel ectodermal cues that 
act locally to pattern specific features of the sea urchin primary mesenchyme network and 
larval endoskeleton. We describe the effects of two gene products, sulfate transporter 
SLC26a2/7 and enzyme 5-lipoxygenase, on PMC migration, positioning, and 
diversification, and the resulting effects on specific features of skeletal morphology. The 
results described herein expand both the molecular understanding of the basis of skeletal 
patterning in sea urchin embryos and the analytical toolkits for studying this model for 
developmental morphogenesis. 
1.4 Development of strategies for 3-D patterning analysis 
The sea urchin embryo is a convenient tool to study 3-D pattern formation. It’s 
optical clarity and relative simplicity allow for morphogenetic events to be viewed in 
three dimensions in vivo. However, current analytical techniques are very limited. 
Because embryos in culture tend to swim erratically, live imaging has been challenging 




are required to piece together coordinated movement. Additionally, spatial information 
about PMC position and mRNA expression analysis is limited to the interpretation of 2-D 
images, or subjectively interpreted from confocal z-projected images. These techniques 
are sufficient to interpret the effects of broad morphogenetic regulators, but lack the 
spatial resolution to quantitatively assess PMC population dynamics in three dimensions. 
We now appreciate that the expression profiles of individual PMCs diversify throughout 
skeletogenesis (Croce et al., 2003a; Gross et al., 2003; Rafiq et al., 2012; Sun and 
Ettensohn, 2014), necessitating the collection of expression information with single cell 
resolution. 
Here, we develop a technique that combines fluorescence in situ hybridization 
with fluorescence immunolabeling to image, then map the positions and expression 
profiles of individual PMCs. This approach allows for the analysis of multiple aspects of 
PMC population dynamics, including local and global spatial configurations and 
distributions, as well as expression profiles of PMC subset genes with single cell 
resolution. Applications of this technique will be discussed in Chapter Two. 
1.5 Roles for sulfated proteoglycans in development 
In Chapter Three, we identify and discuss the role of a sulfate transporter, 
SLC26a2/7 (SLC), in skeletal morphogenesis. We show that SLC is required to generate 
a gradient of sulfated proteoglycans (SPGs) during skeletogenesis, which is required for 
proper PMC migration and skeletal patterning. SPGs represent a ubiquitous family of 
secreted and GP1-anchored glycoproteins with diverse biological roles. They are 




Proteoglycans are structurally heterogenous proteins that are heavily post-translationally 
modified with glycosaminoglycan (GAG) chains (Bernfield et al., 1999). Sulfation of 
GAG chains is a dynamic process, whereby sulfotransferases add sulfate groups, 
sulfatases remove sulfate groups, and sulfated GAG chains are targeted for proteolytic 
cleavage. Together with the availability of sulfate donors, these enzymes create a code of 
sulfation that regulates the biological activity of each SPG molecule (Poulain and Yost, 
2015). In the extracellular matrix, SPGs bind and protect growth factor and other 
signaling ligands from protease degradation, modulating extracellular ligand gradients to 
regulate paracrine signaling (Sarrazin et al., 2011). Membrane-anchored SPGs also 
function to stabilize ligand-receptor interactions (Sarrazin et al., 2011). Both of these 
roles facilitate ligand-mediated cell guidance. In addition to regulating signaling ligand 
stability and presentation, SPGs have also been implicated in direct signaling to SPG 
receptors, specifically in neuronal migration and growth cone stability (Lang et al., 2015). 
SPGs regulate cell proliferation and migration during would healing, cancer, and in 
myriad developmental contexts (Cattaruzza and Perris, 2005). In cancer, cells that are 
unable to synthesize heparan sulfate proteoglycans are incapable of forming metastatic 
tumors in vivo or in vitro (Esko et al., 1988). Together, these mechanisms place SPGs at 
an important nexus for regulating various properties of cell migration and guidance in 
both development and disease. 
1.6 Physiological roles of the lipoxygenase pathway 
In Chapter Four, we define the role of the enzyme 5-lipoxygenase, identified in 




widely distributed across eukaryotes and bacteria, where they serve numerous paracrine, 
autocrine, and endocrine signaling functions (Powell and Rokach, 2015). They participate 
in the complex eicosanoid signaling pathway by oxygenating arachidonic acid (AA) at 
specific carbon atoms, together creating a spectrum of AA metabolites with various 
physiological and pathophysiological roles (Powell and Rokach, 2015). The three main 
lipoxygenase (lox) enzymes are named for the location to which they add an oxygen to 
arachidonic acid; 5-lox, 12-lox, and 15-lox oxygenate the 5th, 12th, or 15th carbon, 
respectively. The resulting molecular species are hydroxyeicosatetraenoic acids (HETEs) 
which signal on their own or are further metabolized by lipoxygenase or dehydrogenase 
enzymes for other signaling purposes (Fig. X) (Powell and Rokach, 2015). In this 
chapter, we identify sea urchin 5-lipoxygenase and its product 5(S)-HETE as skeletal 
patterning cues, and demonstrate that this pathway regulates the expression of the PMC 
subset-specific gene pks2. 
 In humans and mice, the 5-lox gene is primarily expressed in inflammatory cells 
as part of the innate immune response (Radmark et al., 2007; Evans et al., 2008). Genetic 
knockdowns in mice yield no developmental abnormalities, and no role has been 
identified for 5-lox during embryogenesis in other model organisms, which suggested that 
5-lox primarily plays a functional role in adult organisms. The 5-LOX product 5(S)-
HETE and its metabolic derivative 5-oxo-ETE are known to activate and provoke the 
migration of neutrophils (O'Flaherty et al., 1988; Flores et al., 1993) and participate in 
tumor formation by enhancing cellular proliferation and migration. In human 




coupled receptor, OXER1, while in other species the receptors vary or have not been 
identified (Jones et al., 2003; Hosoi et al., 2005). The pro-migratory roles of 5(S)-HETE 
suggests that 5-lox is a logical candidate for a tissue patterning gene. Indeed, we identify 
a novel role for 5-lox as a chemotactic agent and morphogenetic cue for mesenchymal 
cells during sea urchin embryogenesis. 
1.7 A model for coordinated 3-D positioning of PMCs 
		 Past and present studies reveal that the positioning of PMCs during sea urchin 
skeletogenesis is an intricately coordinated set of morphogenetic events, requiring 
multiple levels of regulation. Following specification, PMCs are directed by numerous 
ectodermal cues to migrate, diversify, and secrete skeletal biomineral. Several cues, 
notably VEGF, render PMCs competent for migration and biomineralization: VEGF 
signaling is required for PMCs to execute both tasks. Further ectodermal cues likely 
function to exert specific local effects on PMCs, creating spatially diverse PMC 
subpopulations, each with defined morphogenetic roles. We first identify sulfate 
transporter SLC26a2/6 and demonstrate that it generates a gradient of proteoglycan 
sulfation which is necessary and sufficient to attract PMCs to the ventral territory and 
thereby pattern ventrally positioned elements of the skeleton. The enzyme 5-
lipoxygenase, also expressed in the ventral ectoderm, secretes the pro-migratory cue 
5(S)-HETE, which directs skeletal halves to rotationally align, then provokes migration 
out of ventrolateral clusters and fine-tunes inter-PMC spacing, promoting ventral element 
growth. Both SLC and 5-lox participate in the diversification of PMCs, enabling 




morphogenetic properties to PMCs, thereby conveying the regulative complexity required 






Figure 1.1 Embryonic development of the sea urchin Lytechinus variegatus. 
Schematic (top panels) and DIC images (bottom panels) of live embryos at indicated 
stages of embryonic development and the approximate hours post-fertilization at which 
each stage is observed. Ectoderm and mesoderm are depicted in grey, primary 
mesenchyme cells in red, secondary mesenchyme cells in orange, and skeletal elements 
in yellow. PMCs arise at the mesenchyme blastula stage and initiate synthesis of the 
skeleton at late gastrula. Skeletogenesis continues through the larval stage. Abrreviations: 






Figure 1.2 Spatio-temporal expression profiles of PMC-specific genes.  Schematic 
representation of gene expression patterns within the PMC population of 






Spatially mapping gene expression in sea urchin primary mesenchyme cells 
 This work has been published as: Zuch DT and Bradham CA. Spatially mapping 
gene expression in sea urchin primary mesenchyme cells. Methods in Cell Biology. 2019 
Apr 12; 151:433-442 
2.1 Abstract 
During sea urchin embryogenesis, primary mesenchyme cells (PMCs) follow a 
stereotypical migratory program, arrange into a primary pattern, then begin to secrete a 
bilaterally symmetric calcium carbonate skeleton. Recently identified genes are expressed 
in spatially-restricted domains within the PMC population (Sun and Ettensohn, 2014). To 
better understand the molecular mechanisms orchestrating PMC positioning, we are 
characterizing the expression profiles of PMC subset-specific genes. To deconvolve the 
spatiotemporal expression patterns within PMCs, we detect cell-specific mRNA 
expression with combined RNA fluorescence in situ hybridization and immunolabeling 
of PMCs. Subsequent confocal microscopy provides 3D position and expression 
information for individual PMCs. We extract PMC positions and relative gene expression 
levels, then model these results using open-source 3D modeling software. This versatile 
protocol can be extended to other models and systems 
2.2 Introduction 
 Morphogenesis and tissue patterning are inherently challenging processes to 
study. The diverse array of signals and cell types required to correctly build 




dynamic system. During embryonic development, cells deploy hierarchical gene 
regulatory networks to coordinate spatially-localized proliferation, diversification, and 
migration (Davidson, 2010). As development progresses, cells organize and become 
increasingly specialized, driving the formation of increasingly sophisticated structures. 
This system of tightly coordinated processes is capable of generating three-dimensional 
tissues and living organisms with remarkable fidelity (McIntyre et al., 2014).  
There are several major impediments to deconstructing the mechanisms underlying these 
events. First, the complex signaling environment required for tissue patterning limits the 
use of many in vitro or reductionist experimental approaches. Second, dynamic cellular 
rearrangements in mesenchymal tissues confound the interpretation of signaling 
exchanges and expression shifts between individual cells. Third, current methods for the 
visualization, interpretation, and analysis of tissue architecture and gene expression in 
three-dimensions are unintuitive and offer very little user-side flexibility. Gene 
expression is particularly challenging to interpret on a cellular level, as cellular 
boundaries are largely indistinguishable in tissues subjected to RNA FISH. Transcripts 
which are abundant in broad regions of tissue tend to generate amorphous clouds of FISH 
signal, which obscure the contributions of internal cells. In addition, the punctate signal 
produced by tyramide-amplified FISH does not highlight cell shape like a uniform 
cytoplasmic signal might. 
Using sea urchin embryos as a model system, we have developed a protocol that 
ameliorates many of the challenges inherent to studying tissue patterning. Our method 




followed by 3D mapping of cellular positions and expression profiles. The sea urchin 
embryo provides a tractable platform to examine patterning of migratory cells during 
development. Sea urchin embryos are transparent, genetically simple compared to 
vertebrates, and can be generated in large, synchronously developing cultures for high 
throughput analysis. They produce a bilaterally symmetric calcium carbonate skeleton, 
which provides a visual, non-invasive readout of patterning in real-time. During 
embryogenesis, the larval endoskeleton is secreted by a relatively uniform population of 
migratory primary mesenchyme cells (Fig. 2.1).  These cells are directed by cues from 
the overlying ectoderm to arrange into a stereotypic three-dimensional pattern, forming a 
syncytial network along which skeletal biomineral is deposited (McIntyre et al., 2014). 
The cellular arrangement evolves predictably as embryogenesis progresses, defining the 
shape of the mature skeleton. As PMCs migrate, they diversify into distinct subsets with 
spatially-defined gene expression profiles (Sun and Ettensohn, 2014) (Fig. 2.2). Several 
recently identified subset-specific genes display a dynamic yet predictable expression 
pattern that varies as a function of embryonic stage, PMC position, and the 
presence/activity of localized ectodermal cues, suggesting that ectodermal cues and 
subset genes cooperate to accurately position PMCs for 3D skeletal pattern formation 
(Piacentino et al., 2016). Identifying the mechanisms that drive this coordinated cellular 
dance requires an accurate scrutiny of spatial relationships and expression patterns with 
single-cell resolution. 




 Currently, analysis of tissue patterning on a cellular level is largely restricted to 
visual inspection of z-projected images, pseudo-3D z-projections, and in certain cases, 
volume rendering. Gene expression analysis with RNA FISH is particularly difficult to 
interpret in 3D, as cytoplasmic signals have no clear cellular boundary in densely packed 
tissues (Fig. 2.3). In addition, most current forms of 3D or pseudo-3D visualization offer 
very few options for perspective adjustment, which can lead to incomplete and/or biased 
data collection and interpretation. Because it can often be difficult to control the 
orientation in which samples are imaged, cross-sample comparisons of spatial 
relationships can be prohibitively time-consuming and abstract, mathematically intensive, 
and in some cases impossible. In addition, most datasets containing 3D information are 
temporal snapshots, making it difficult to extrapolate migratory behavior of individual 
cells. 
The availability of sophisticated 3D modeling software has afforded several 
unique approaches to aid in the interpretation, analysis, and presentation of tissue 
patterning information. Our method uses the Blender open source creation suite 
(www.Blender.org), but can be easily adapted to multiple platforms. The most immediate 
advantage to working with a 3D modeling suite is the flexibility of data visualization. 
Blender’s comprehensive graphical user interface allows data to be represented and 
viewed in highly customizable configurations, offering flexible strategies for data 
representation as well as unique perspectives into cellular relationships. A nearly 
unlimited range of structures can be represented, including individual cells, 




2.4). Supporting information such as polarity, gene expression, cell type, cell shape and 
size can be visually encoded, providing the opportunity to draw correlations between 
gene expression and phenotype of individual cells. Unrestricted navigation of data in 3D 
space allows exploration of structures and cellular relationships at scales and perspectives 
that are unattainable with most z-projection and volume rendering approaches (Fig. 2.5). 
We have applied this method in sea urchin embryos to identify and characterize novel 
cellular arrangements and expression patterns, predict cell movements, map temporal 
dynamics, and develop novel analytical methods for our system. 3D mapping is 
particularly useful as a tool to corroborate quantitative spatial information calculated 
from raw data, including volumetric cell density measurements, inter-cell 
distance/proximity measurements, morphological length/angle/rotation measurements, 
and characterization of multi-cell arrangements using tools like principle component 
analysis. 
 A range of qualitative/indirect information can also be extracted visually from 3D 
data. In sea urchin embryos, we are able to visually define spatial regions and assign cells 
to groups, then count cells by region or group. Cells can be colorized according to gene 
expression level or group assignment.  Text, bounding boxes, and line/arrow annotations 
can be added directly in the 3D environment (Fig. 2.6). 
2.4 Method 
The following method can be used to enhance/expand the analytical toolkit for 3D 
tissue patterning analysis. Here, we present a novel approach to mapping gene expression 




Z-stacked confocal microscopy images, FIJI (or ImageJ with a Bioformats package 
installed), Microsoft Excel or similar, and Blender. We will describe specific approaches 
used in sea urchin as well as general recommendations. The protocol is highly flexible 
and can likely be extended to any 3D system. 
Raw data should comprise a series of X by Y images, separated by Z depth. Depending 
on the application, points of interest can be collected manually using ImageJ/FIJI, or 
computationally using Matlab, R, Python, or other image processing packages. Points of 
interest containing X, Y and Z coordinates can be individually entered into Blender or 
converted to Blender commands en masse using Python. Once plotted in Blender, 
orientation/translation adjustments, coloration, and annotation are completed manually. 
 
Protocol for Gene Expression Mapping in Sea Urchin Primary Mesenchyme Cells 
1. Embryo fixation 
a. Fix embryos in 4% paraformaldehyde for 1hr at room temperature (RT). 
b. Permeabilize embryos in methanol for at least 30 minutes (min) at -20oC. 
2. RNA Fluorescence in situ hybridization for subset-specific genes. 
a. Synthesize DIG-labeled antisense RNA probe for the gene of interest using in 
vitro transcription (mMessage mMachine Kit, Ambion #Am1340). Purify probes with gel 
exclusion chromatography using spin columns (Stratagene). 




c. Hybridize DIG-labeled probe overnight at 65°C in hybridization buffer (50% 
formamide, 5X SSC buffer, pH5, 50µg/mL yeast tRNA, 50µg/mL Heparin, 0.1% Tween 
20) 
d. Remove unhybridized probe with washes in serial 2X – 0.1X SSCT dilutions at 
65°C. 
e. Block with HISS/BSA (2% heat-inactivated sheep serum plus 5 mg/mL bovine 
serum albumin in PBST) at RT for 2 hours (hr) or overnight at 4°C. 
f. Incubate with anti-DIG conjugated to HRP (horseradish peroxidase, Perkin 
Elmer) in HISS/BSA for 30 min at RT. 
g. Wash several times with PBST. 
h. Develop signal for 6 min with Tyramide Signal Amplification Kit (Perkin-Elmer). 
3. Immunostain PMCs 
a. Transfer embryos into NGS block (4% normal goat serum in PBS with 0.1% 
Triton-X100) 1 hr at RT or overnight at 4°C.  
b. Incubate in primary antibody/NGS block overnight, then wash several times with 
NGS block. 
c. Incubate in anti-mouse Alexa488 (Invitrogen) and Hoechst 33258 in NGS block 
for 1hr, then wash several times with NGS block. 
d. Transfer into 50% glycerol/PBST and mount on glass slides for confocal 
microscopy. We use strips of double-stick tape as convenient spacers for supporting the 
coverslip. 




a. Collect images with sufficient z-resolution to identify cell centers. 
5. Collect 3D coordinates using FIJI 
a. Launch FIJI, then open z-stacked confocal images. 
b. Select the point tool. 
c. Identify a cell or feature of interest 
d. Scroll through z-stacks to identify center of feature 
e. Click on the image containing the feature center to place a point, then press “T” to 
store that point in the ROI manager.   
i. To view all of the points, select the “Show All” and “Labels” checkboxes in the 
ROI manager.   
ii. To associate each point with a particular z-slice, from the ROI manager, navigate 
to” More >>”, then “Options…”, then select “Associate all ROIs with slices”. 
f. Repeat until all features of interest have been identified and stored 
i. If additional information is to be collected, non-point ROIs can be used to 
measure feature size, and/or average pixel intensity per unit area. 
g. In the ROI manager, select “measure” and copy the X,Y,and Z coordinates, as 
well as any accompanying information into a spreadsheet. 
h. If quantitative expression information is to be collected manually, simply scroll 
through the z-stacks and record an expression value for each data point of interest. 
6. Import coordinates into Blender as sphere objects 
a. Store only the X, Y, and Z coordinates to be plotted in the first three columns of a 




b. Create and save an empty .txt file using Notepad (Windows) or TextEdit (Mac).  
c. Download the csv_to_blenderspheres.py script from 
http://www.github.com/BradhamLab/Blender 
d. In a unix terminal, run the following command: python <path to 
csv2blender_sphere.py> <path to CSV file> <path to empty .txt file) 
e. The .txt file will now contain Blender commands. Copy the output text. The 
syntax for a single sphere entry should appear as follows: 
"bpy.ops.mesh.primitive_uv_sphere_add(segments=32, ring_count=16, size=0.5, 
view_align=False, enter_editmode=False, location=(X,Y,Z), rotation=(0,0,0), 
layers=(True,False,False,False,False,False,False,False,False,False,False,False,False,False
,False,False,False,False,False,False))". 
f. Open Blender, navigate to the Scripting window, then paste the copied text into 
the python console. Press enter. 
g. Points will be represented as sphere objects in the Default layout. 
• The script can be modified to adjust object size or type. 
• Alternatively, objects can be added manually as described in the Blender user 
manual  
7. Translation, coloration, annotation 
• Detailed instructions are available in the Blender user manual at 
http://www.Blender.org 
a. Translation can be achieved by linking all objects of interest to a parent object, 




b. Coloration can be applied by adding a material to an object, then adjusting the 
diffuse color in the material properties menu. Once created, materials can be applied to 
multiple objects. 
c. Annotation can be achieved by simply adding mesh or text objects.  
i. Create bounding boxes by changing an object’s material type from “Surface” to 
“Wire”. 
ii. Text can be edited by pressing the tab key to enter edit mode. Change the text, 
then press tab again to exit edit mode 
2.5 Conclusions 
This protocol describes a corroborative visual tool for analyzing and presenting 
3D biological data. We have applied this method in sea urchin embryos to better interpret 
the spatial organization of cells and gene expression patterns within the migratory 
primary mesenchyme population.   
Complex cell arrangements, punctate fluorescent signals, background noise, and 
variable tissue clarity can lead to difficulties in interpreting confocal z-stack projections.  
Clusters of fluorescently labeled cells often conceal internal structures, which can lead to 
data loss. Our method relies on slice-by-slice data collection to identify and spatially map 
features of interest, then to visualize those features in an isolated, interactive 3D space.  
As a supplement to raw data, this versatile tool can drastically improve the 
interpretability of projected z-stacks of fluorescent confocal microscopy images. Blender 
models can be viewed from any perspective, unlike confocal z-stacks; thus, embryos can 




The protocol as described serves as both a stand-alone approach and a simplified 
foundation for the development of application-specific analytical tools. Image recognition 
and machine-learning approaches for automated cell identification in confocal datasets 
are currently being developed to enhance the efficiency of data collection. Blender’s 
physics engine also enables temporal extrapolation of cell movements and predictive 
multi-variable hypothesis testing by simulating chemotaxis, dynamic cell-cell 
interactions, and physical forces between objects. 
In addition to data analysis, this 3D mapping protocol presents an extremely 
useful toolkit for sharing and teaching morphological and developmental findings. The 
ability to simplify, color-code, annotate, and animate 3D models can transform a 






Figure 2.1 PMCs secrete the larval endoskeleton A. A schematic depicting the 
development of L. variegatus embryos through 48 hours post-fertilization (hpf). PMCs 
are depicted in red, and the skeleton in yellow. B. PMCs migrate to form a stereotypic 
‘ring and cords’ pattern just prior to initiation of skeletogenesis, around 18 hpf. Skeletal 
spicules form in the ventrolateral clusters (upper panels), then elongate as PMCs migrate 
and secrete calcium carbonate, forming the mature 4-armed larval endoskeleton at 48 hpf 
(lower panels). PMCs are immunolabeled with the 6a9 antibody (red, center panels). 
Skeleton birefringence is imaged using polarized light microscopy (right panels). C. A 
model for skeletal patterning, in which PMCs receive instructive cues from the ectoderm 







Figure 2.2 Representative 3-D models of gene expression during primary migration 
of the PMC population. Stereotypic primary migration of PMCs over time is 
represented as 3D sphere models. Expression patterns for tbx2/3 (A), frp (B) and pks2 
(C) were scored for location and intensity within the PMC population by FISH and 
confocal microscopy at the indicated time points (hpf). 3-D models were then color-
coded to represent relative expression intensity. Darker color represents higher levels of 
expression. Snapshots of PMC migration between 12 and 18 hours post-fertilization were 






Figure 2.3 3-D modeling of cells in embryos subjected to a combination of FISH and 
immunolabeling. A-C: Confocal z-stack maximum projections showing immunolabeled 
PMCs (A, red) and the FISH signal for the transcription factor tbx2/3, which is present in 
dorsal PMCs, endoderm, and ectoderm. Both signals are merged in C, which allows 
tbx2/3 expression levels to be assigned to individual PMCs. D. Model of PMC locations 
(spheres) and binarized tbx2/3 expression (red color), extracted from confocal image 






Figure 2.4 Modeling of morphological structures. A. A maximum z-stack confocal 
projection of immunolabeled PMCs in a larva with a perturbed skeleton. PMC cell 
bodies, skeletal rods, and filopodia are visible when PMC membranes are 
immunostained, since the PMC membranes exhibit filopodial protrusions and encase the 
entire skeleton. B.-E. 3-D models were extracted from the z-projection in A. Skeletal 
rods were mapped by extracting endpoints from junctions or ends of the hollow tube-like 
structures visible in panel A, then represented as thin cylinders (B). PMCs were mapped 
by manual inspection of cell bodies or nuclei centroids from Hoechst staining, then 
represented as spheres (C). Filopodia were mapped manually by recording endpoints and 







Figure 2.5 Blender visualizations allow orthographic and perspective views. 
Blender’s “Quad View” feature, illustrated here, enables simultaneous perspective and 
multi-axis orthographic views. A representative model of PMCs was colorized to 
represent spatially distinct PMC domains. Multiple views and perspectives provide a 






Figure 2.6	Annotations can be incorporated in the 3D environment in Blender. 
 A representative PMC model was colorized by spatial domain, and labeled with text, 






RNA-Seq identifies SPGs as a ventral skeletal patterning cue in sea urchins 
 
	 This study includes contributions from many fellow graduate students in the 
Biology and Bioinformatics departments, undergraduate students whom I have trained 
and mentored, other undergraduate students in the lab, and external collaborators. RNA-
Seq sample collection was performed by Amanda Core, and sequenced by Jonas Ibn-
Salem and Albert Poustka. Bioinformatics analyses were performed by Emily Speranza, 
John D. Hogan, Jessica Keenan, Lingqi Luo, Jasmin Coulombe-Huntington, and Cynthia 
A. Bradham. This data has been incorporated into Figures 3.2 and 3.3. Biological 
analyses that compose the remaining figures were performed by Michael Piacentino, Julie 
Fishman, Sviatlana Rose, Christy Li, Jia Yu, Oliver Chung, Janani Ramachandran, Pat 
Ferrell, Vijeta Patel, Arlene Reyna, Hajerah Hameeduddin, James Chaves, Finnegan B. 
Hewitt, Evan Bardot, David Lee, Todd Blute, and me. My specific contributions include 
participation in cloning full length LvSLC, SLC MO target splice analysis (Fig 3.5), 
experiment design: including low and high sulfate conditions involved in analyses 
throughout the chapter, biological treatments, morpholino and mRNA injections involved 
in analyses throughout the chapter, alcian blue and cuprolinic acid staining (Figs. 3.7 and 
3.9), PMC immunolabeling and tbx2/3 FISH, gene expression mapping, and analysis 
(Fig. 3.11), and generating technical replicates. 
This work has been published as: Piacentino ML, Zuch D, Fishman J, Rose S, 
Speranza EE, Li C, Yu J, Chung O, Ramachandran J, Ferrell P, Patel V, Reyna A, 




JL, Luo L, Coulombe-Huntington J, Blute TA, Oleinik E, Ibn-Salem J, Poustka AJ, 
Bradham CA. RNA-Seq identifies SPGs a ventral skeletal patterning cue in sea urchins. 
Development. 2016 Feb 15;143(4):703-14 
3.1 Abstract 
The sea urchin larval skeleton offers a simple model for developmental pattern 
formation. The calcium carbonate skeleton is secreted by primary mesenchyme cells 
(PMCs) in response to largely unknown patterning cues expressed by the ectoderm. To 
discover novel ectodermal cues, we performed an unbiased RNA-seq-based screen and 
functionally tested candidates; we thereby identified several novel skeletal patterning 
cues. Among these, we show that SLC26a2/7 is a ventrally expressed sulfate transporter 
which promotes a ventral accumulation of sulfated proteoglycans that is required for 
ventral PMC positioning and skeletal patterning. We show that the effects of SLC 
perturbation are mimicked by manipulation of either external sulfate levels or 
proteoglycan sulfation. These results demonstrate that ventral proteoglycan sulfation 
serves as a positional cue for the sea urchin skeletal patterning.  
3.2 Introduction 
 Patterning the larval skeleton in sea urchin embryos is a fascinating process in 
which statically positioned ectodermal cells direct the migration and positioning of 
primary mesenchymal cells (PMCs), which secrete a calcium carbonate skeleton via 
biomineralization (Lyons et al., 2011). During gastrulation, the PMCs ingress into the 
blastocoel, then migrate and organize into a posterior ring around the blastopore with two 




This initial ring-and-cords PMC organization gives rise to the primary skeletal elements, 
while additional migration out of this pattern is required to form the secondary skeletal 
elements (see Fig. 3.10 A,B for schematics illustrating primary and secondary skeletal 
patterning).   
 von Ubisch first suggested that the ectoderm provides patterning instructions to 
the PMCs in the 1930s (von Ubisch, 1937), and in the early 1960s, Gustafson and 
Wolpert demonstrated that the posterior PMC ring is actively positioned by anteriorizing 
the ectoderm and showing that the ring was correspondingly repositioned (Gustafson and 
Wolpert, 1961). In the 1990s, Armstrong, Hardin, and McClay used microsurgical 
transplants to demonstrated that the Ni-mediated patterning defect was specific to the 
ectoderm and not the PMCs (Armstrong et al., 1993). Subsequent experiments have 
confirmed and corroborated these results (reviewed by (Adomako-Ankomah and 
Ettensohn, 2014; McIntyre et al., 2014)). Throughout their migration, the PMCs extend 
thin filopodia that contact the ectoderm (Gustafson and Wolpert, 1961; Miller et al., 
1995). These observations led to the widely accepted hypothesis that the filopodia act as 
conduits for receiving patterning information from the ectoderm.  
Recent studies have identified ectodermal genes that regulate PMC migration and 
skeletogenesis. These include the tripartite motif-containing protein Strim1, the 
transcription factors Pax2/5/8 and Otp, and the signaling ligands FGF, Wnt5a, VEGF, 
and the TGF-ß ligand Univin. These genes are expressed in the ectoderm directly 
adjacent to sites of active biomineralization, and with the exception of Univin, which is 




2015b), their loss of function (LOF) blocks skeletogenesis, indicating a role in regulating 
biomineralization (Di Bernardo et al., 1999; Cavalieri et al., 2003b; Duloquin et al., 2007; 
Rottinger et al., 2008; Cavalieri et al., 2011; Adomako-Ankomah and Ettensohn, 2013b). 
Gene products that specifically regulate primary PMC positioning but not 
biomineralization remain largely undiscovered. 
 In contrast with the identity of ectodermal skeletal patterning cues, ectodermal 
specification is better understood. Specification of the ventral ectoderm relies on the 
asymmetric activation of Nodal expression and signaling, which in turn depends on 
asymmetric p38 activation (Duboc et al., 2004; Flowers et al., 2004; Bradham and 
McClay, 2006). Nodal induces the ventral expression of BMP2/4, which signals only 
outside the ventral region to induce dorsal ectodermal specification (Angerer et al., 2000; 
Duboc et al., 2004). A neurogenic ciliated band develops at the DV boundary; this default 
ectodermal state is suppressed by both Nodal and BMP2/4 signaling (Duboc et al., 2004; 
Bradham et al., 2009; Lapraz et al., 2009; Yaguchi et al., 2010b). Gene regulatory 
network models describing ectodermal specification are now established (Su et al., 
2009a; Saudemont et al., 2010b; Barsi et al., 2015), as are initial mathematical models 
describing BMP2/4 movement in sea urchin embryos (van Heijster et al., 2014). 
 In this study, we present results from an RNA-seq-based screen with which we 
identify novel skeletal patterning genes. LOF analyses indicate that each tested gene is 
required for normal PMC positioning and skeletal patterning, but not for 
biomineralization. One such candidate, LvSLC26a2/7, is a sulfate transporter that is 




demonstrate that ventral SPGs are required to attract PMCs into the ventral portion of the 
PMC ring, and thereby, to pattern the ventral skeletal rods. 
3.3 Materials and Methods 
3.3.1 Animals, perturbations, surgeries, imaging, and skeletal scoring 
Adult Lytechinus variegatus sea urchins were obtained from the Duke University 
Marine Laboratory (Beaufort, NC) or from Reeftopia (Miami, FL). Gamete harvesting, 
embryo culturing and microinjection were performed as described (Bradham and 
McClay, 2006). See supplementary Materials and Methods and Table S3 for additional 
details. Microsurgeries to produce chimeras were performed as described (Armstrong et 
al., 1993). Larval skeletons were imaged in multiple focal planes, which were manually 
recombined into montage images using Canvas (ACD Systems) to present complete 
larval skeleton in focus, for clarity. The full set of skeletal images was used for scoring, 
as described in Fig. S7 
3.3.2 RNA-Seq, data assembly, and analysis 
Total RNA was polyA selected, then cDNA libraries were prepared and 
sequenced on an Illumina GAII platform. 101 bp paired-end reads were initially 
assembled using SOAPdenovo (Li et al., 2010), and finally assembled using 
SOAPdenovo-Trans (Xie et al., 2014). Transcriptome assembly and annotation will be 
described elsewhere and are available at NCBI (BioProject accession number 
PRJNA241187; J. D. Hogan, J.L.K., L.L., E.E.S., A. Saji, M. A. Sundermeyer, D. 
Schatzberg, M.L.P., D.T.Z., A.B.C., C. Blumberg, J.I.-S., B. Timmerman, J. G. Grau, N. 




DESeq (Anders and Huber, 2010). MA plots were generated in R (R Core Team, 2014). 
GO term enrichment analysis was performed with iPAGE (Goodarzi et al., 2009) and 
metabolic maps were generated with iPath 2.0 (Yamada et al., 2011). 
3.3.3 Skeletal patterning candidate selection rationale 
Candidates were selected from an initial list of 879 scaffolds whose expression 
level (normalized counts) was downregulated in both Ni and SB by ≥ 2-fold compared to 
control. Of these, 114 genes were identifiable. 77 of these encode extracellular proteins 
(based on orthology), and we manually selected candidates from among this short list. 
LvSLC26a2/7 was selected because of its orthology to a mammalian skeletal patterning 
gene (Mount and Romero, 2004). LvNFL (Notch- and Fibropellin-like) and LvSVEP 
(sushi-von Willebrand factor type A- EGF- pendraxin domain-1) were selected because 
of their probable adhesive functions (Bisgrove et al., 1991; Shur et al., 2006), which we 
reasoned are likely to contribute to ectodermal patterning mechanisms. LvLOX 
(lipoxygenase) was selected because LOX-produced HETEs regulate a range of signaling 
pathways (Pidgeon et al., 2007). LvST14 (suppressor of tumorgenicity 14, also known as 
matriptase) was selected because it is a protease that targets the ECM and is implicated in 
regulating cell migration (List et al., 2006). Finally, LvBMP5-8 was selected because it is 
a well-known signaling ligand, and because it was upregulated by Ni and SB in the initial 
assembly, and therefore reflected a mutually upregulated candidate. 
3.3.4 Candidate gene sequence analysis 
Candidate gene sequence reads were used to assemble provisional gene models, 




Intron positions were predicted based on corresponding intron positions in S. purpuratus 
((Sodergren et al., 2006), http://www.echinobase.org), then amplified, cloned and 
sequenced for splice-blocking MO sequence design. Phylogenetic analysis was 
performed using MrBayes (http://mrbayes.sourceforge.net) and visualized using FigTree 
(http://tree.bio.ed/ac/uk/software/figtree/). Sequence alignment was carried out using 
MultAlin (Corpet, 1988). Full length LvSLC26a2/7 cDNA (GenBank accession number 
KR055815) was obtained by RACE, then subcloned into pCS2 for in vitro transcription, 
after the addition of an artificial polyA track (20mer) in the 3’ UTR to enhance mRNA 
stability in vivo. Relevant LvSLC26a2/7 primer sequences are listed in Table S4. 
3.3.5 Whole mount in situ hybridization 
Full-length riboprobes were labeled with DNP-11-UTP (PerkinElmer) or 
digoxigenin (DIG, Roche). In situ hybridization was performed as described (Bradham et 
al., 2009; Piacentino et al., 2015). 
3.3.6 Immunostaining and confocal microscopy 
Immunolabeling was performed as described (Bradham and McClay, 2006; 
Piacentino et al., 2015). Primary antibodies include PMC-specific 6a9 (1:5; from Charles 
Ettensohn, Carnegie Mellon University, Pittsburgh, PA, USA) and ciliary band-specific 
295 (undiluted; from David McClay, Duke University, Durham, NC, USA). Secondary 
antibodies were goat anti- mouse Cy3 (1:500; Jackson Laboratories) and goat anti-mouse 
Alexa Fluor 488 (1:500; Molecular Probes). All images are full projections of z-stacks. 




ImageJ was used to manually process confocal z-stack images and to define the 
center of each PMC using the multi-point ROI manager; LvTbx2/3 expression was 
manually scored for each PMC. ROI sets were mapped to 3D 
3.3.8 Alcian blue histochemistry, signal quantitation and pseudocoloring, and 
cuprolinic acid staining 
Sea urchin embryos were fixed in 2.5% glutaraldehyde (Polysciences) and 0.025 
M sodium cacodylate (Sigma) in ASW for approximately 24 h, then washed into staining 
solution containing 0.3 M magnesium chloride (MP Biomedicals) and 0.05% Alcian Blue 
cationic dye (Sigma) at pH 2.5 to specifically label sulfated functional groups (Scott and 
Dorling, 1965). After 24h in staining solution, embryos were washed and imaged. See 
supplementary Materials and Methods for details on image processing and quantitation, 
and for the Cuprolinic staining method. 
3.3.9 qPCR Analysis 
qPCR analysis was performed as described (Piacentino et al., 2015). qPCR primer 
sequences are provided in Table S4. 
3.4 Results 
3.4.1 p38 MAPK inhibition in the ectoderm elicits skeletal patterning defects 
The goal of this study was to identify novel skeletal patterning genes in the 
ectoderm of the sea urchin embryo. This project was initiated by the observation that 
Lytechinus variegatus embryos cultured in the presence of the p38 MAPK inhibitor 
SB203580 (SB) prior to gastrulation develop a strongly mispatterned skeleton (Fig. 3.1A) 




microsurgically generated chimeric embryos in which either the PMCs or the ectodermal 
hull only were exposed to SB (Fig. 3.1B). Patterning defects were only observed in 
chimeras in which the hull was exposed to SB (Fig. 3.1C,D), indicating that SB 
specifically impacts the ectoderm and not the PMCs to induce skeletal patterning defects. 
PMC migration was disorganized in SB-treated embryos compared with controls (Fig. 
3.1E,F), consistent with defects in the ectodermal cues that mediate PMC positioning. 
Interestingly, the PMCs in SB-treated embryos progressively displayed excessively 
numerous and elongated filopodia during gastrulation, which were most conspicuous at 
late gastrula (LG) stage (Fig. 3.1F). Filopodia extended by the PMCs are likely to be 
conduits of information between the ectoderm and the PMCs (Miller et al., 1995; Lyons 
et al., 2011); the abnormal filopodia observed in SB-treated embryos likely reflect a 
response to abnormal ectodermal patterning information. 
Interestingly, the radial defect in skeletal patterning, its ectodermal dependence, 
and the abnormal filopodia induced by SB treatment are each similar to the effects of 
NiCl2 (Hardin et al., 1992; Armstrong et al., 1993; Miller et al., 1995). Thus, both Ni- and 
SB-treated embryos exhibit characteristics consistent with abnormal ectodermal 
patterning information, including the spatial disordering of the PMCs, their excessive 
filopodial extensions, and the abnormal skeletons eventually produced. These results 
suggested the hypothesis that skeletal patterning cues are similarly perturbed in the 
ectoderm of both Ni- and SB-treated embryos. We reasoned that the simplest explanation 
for these observations is a loss of ectodermal patterning gene expression with Ni or SB, 




recognized that it is also possible that increased and/or ectopically expressed cues are 
responsible for these effects.  
3.4.2 SB and Ni have opposite effects on ectodermal specification and differentiation 
Ni treatment provokes ectodermal ventralization, while SB treatment blocks it 
(Hardin et al., 1992; Bradham and McClay, 2006). We confirmed these effects by 
comparing the expression of dorsal and ventral specification markers, and by labeling the 
ciliary band, which is sensitive to dorsal-ventral (DV) perturbations (Yaguchi et al., 
2010b). Ni exposure resulted in radial expansion of the ventral marker nodal, loss of the 
dorsal marker tbx2/3, and abnormal restriction of the ciliary band to the posterior region 
of the embryo (Fig. 3.1Gb,Hb,Ib), consistent with ventralization. In contrast, SB exposure 
provoked the opposite effects, with a loss of nodal expression, radial expansion of tbx2/3, 
and loss of restriction of the ciliary band (Fig. 3.1Gc,Hc,Ic), consistent with a pre-
ventralized ectodermal state (Duboc et al., 2004; Bradham and McClay, 2006). These 
results indicate that Ni and SB have distinct effects on DV specification and 
differentiation in the ectoderm. This conclusion led us to predict that Ni and SB 
treatments would provoke reciprocal effects on the expression of genes involved with DV 
specification (“DV genes”) in the ectoderm. 
3.4.3 A differential RNA-Seq screen identifies novel skeletal patterning genes 
The combined observations that Ni and SB each provoke similar effects on 
skeletal patterning and opposite effects on ectodermal DV specification provided an 
opportunity to identify ectodermal skeletal patterning genes, which we predicted would 




distinguishable from DV genes, which we predicted would be reciprocally regulated by 
Ni and SB (Fig. 3.2A). We further predicted that most non-ectodermal genes would be 
unaffected by either treatment (Fig. 3.2A). Finally, we predicted that ectodermal skeletal 
patterning genes would encode proteins that are associated with the cell surface or 
secreted, as mediators of communication between the ectoderm and the PMCs.  
Following this rationale, we used RNA-Seq to compare the transcriptomes from 
control, Ni- and SB-treated embryos at LG stage, and focused on genes downregulated by 
Ni and SB. An early transcriptome assembly was used to identify candidates 
downregulated by both Ni and SB (“mutually downregulated”, cut-off ≥ 2-fold), which 
corresponded to a minority subset of the total transcriptome (Fig. 3.3A), and which, for 
the identifiable subset, exhibited an approximately 2-fold enrichment of sequences 
encoding cell surface or secreted proteins (Fig. 3.3B). For the final assembly, DESeq was 
used to normalize and compare the transcriptomes (Fig. 3.2B-F). The fraction of mutually 
downregulated sequences increased in the final assembly, reflecting substantially 
improved gene models and annotations, while the enrichment of cell surface and secreted 
sequences was maintained (Fig. 3.2C,D). We selected multiple candidates for testing 
from the initial list (Table 3.1; see supplementary materials and methods for the rationale 
for candidate selection), along with one candidate that was upregulated by both 
treatments in the initial assembly. The directionality of the expression differences for the 
selected candidates was maintained in the final assembly, although in some cases, the 
magnitude of change was reduced (Fig. 3.3C); most validated candidate sequences from 




3.2E,F). Genes previously implicated in regulating skeletal patterning exhibited 
reciprocal rather than mutual regulation by Ni and SB (Fig. 3.2E,F). iPAGE analysis 
(Goodarzi et al., 2009) shows that GO terms associated with cell surface or extracellular 
processes (i.e. GPCRs, scavenger receptors, and transporters) were enriched in the 
mutually down-regulated set of transcripts (Fig. 3.2G). We also observed enrichment of 
GO terms associated with fatty acid biosynthesis and sulfotransferase activity. The final 
candidate genes are listed in Table 3.2. 
To gain a more comprehensive view of the impact of Ni and SB on gene 
expression, we examined the expression of previously characterized genes (Fig. 3.3D-H). 
As expected, most genes involved in ventral ectodermal specification were upregulated 
by Ni and downregulated by SB (Fig. 3.3D). Genes involved in dorsal ectodermal 
specification were downregulated by Ni, and not strongly impacted by SB (Fig. 3.3E). 
Most endomesodermal specification genes were not strongly affected by Ni or SB (Fig. 
3.3F-H), with the exception of known dorsal and ventral secondary mesenchyme cell 
(SMC) genes, which responded reciprocally to Ni and SB, and coelomic/germline genes, 
which were downregulated by SB. Among this set of 81 genes, only one, SM30, 
exhibited downregulation by both Ni and SB. SM30 is a biomineralization gene whose 
protein products are incorporated into the skeleton. Surprisingly, SM30 was recently 
shown to be dispensable for skeletogenesis (Wilt et al., 2013b). Thus, most of the known 
specification and differentiation genes responded as expected to Ni and SB treatments. 
To investigate the behavior of the metabolic network in Ni- and SB-treated embryos, we 




metabolic genes were affected by either treatment (Fig. 3.3I,J). Together, these results are 
consistent with the predictions schematized in Figure 2A. 
 We selected five candidate genes for functional analysis based on their “double 
down” expression profiles (Fig. 3.3C). One final candidate gene, BMP5-8, was selected 
based on its “double up” behavior. Phylogenetic analyses confirmed the annotations for 
these candidate genes (Fig. 3.4B-G). To perform functional analyses, we designed 
translation- or splice-blocking morpholino antisense oligonucleotides (MOs) (Fig. 3.4A). 
In all six cases, loss of function (LOF) resulted in plutei that displayed dramatic, 
previously unreported skeletal patterning defects (Fig. 3.2H,I), indicating that each 
candidate is required for normal skeletal patterning. Notably, while both Ni and SB 
treatments provoked radialized skeletons that reflect DV perturbations, none of the 
candidate LOF phenotypes were radialized. In addition, none of the morphants exhibit a 
block to biomineralization, since all the PMCs within these larvae were associated with 
skeletal elements (Fig. 3.2J). Thus, these LOF effects are distinct from those produced by 
VEGF/R, Wnt5a, Otp, Pax2/5/8 or FGF knockdown, since each of these blocks 
biomineralization, resulting in larvae that lack skeletons entirely (Di Bernardo et al., 
1999; Cavalieri et al., 2003b; Duloquin et al., 2007; Rottinger et al., 2008; Cavalieri et 
al., 2011; Adomako-Ankomah and Ettensohn, 2013b; McIntyre et al., 2013a). Further, 
each candidate LOF resulted in perturbed PMC organization at LG stage (Fig. 3.2K), 
indicating that each gene is required for normal PMC positioning. Finally, we tested 
ectodermal DV specification by labeling the ciliary band in the LOF embryos. The results 




that DV specification of the ectoderm is normal in candidate gene morphants. These 
results show that the skeletal patterning defects observed in candidate gene morphants do 
not result from DV perturbations, consistent with their non-radialized phenotypes. 
Together, these results demonstrate that the RNA-Seq screen successfully identified 
novel genes that are required for normal skeletal patterning and PMC positioning, but not 
for ectodermal DV specification.  
3.4.4 LvSLC26a2/7 encodes a sulfate transporter that is required for production of 
sulfated proteoglycans 
We focused on one of the candidates that was annotated as a member of the 
SLC26 family of transmembrane ion transporters. Knockdown of this transporter resulted 
in significant loss of primary skeletal elements and perturbed PMC positioning (Fig. 
3.2Ib,Jb,Kb). Phylogenetic analyses and sequence alignments place this gene between the 
vertebrate SLC26a2 and SLC26a7 genes (Figs 3.4B and 3.6B); we will therefore refer to 
this gene as LvSLC26a2/7 (SLC). Domain analysis shows that SLC encodes a 10-pass 
transmembrane protein with domains characteristic of sulfate transporter genes (Fig. 
3.6A). At LG stage, SLC is expressed in the ventral ectoderm, extending from the 
posterior to the anterior pole, as well as in the blastopore and endoderm (Fig. 3.7A). SLC 
expression is maintained throughout early development and is downregulated following 
gastrulation (Fig. 3.7B). Thus, SLC is expressed at the correct time and place to 
contribute to PMC positioning and skeletal patterning. SLC expression is downregulated 





 The vertebrate SLC26a2 ortholog encodes a sulfate transporter that is required for 
the sulfation of proteoglycans (PGs) (Mount and Romero, 2004). SLC26a2 mutation 
causes the human disorder diastrophic dysplasia, hallmarked by a range of cartilage 
defects and dwarfism; similar effects occur in SLC26a2 knockout mice, along with 
skeletal patterning defects. These defects result from reduced sulfation of PGs during 
chondrogenesis, which in turn reduces FGF and Ihh signaling, interfering with skeletal 
growth (Rossi et al., 1998; Mount and Romero, 2004; Forlino et al., 2005; Gualeni et al., 
2010). These findings suggested that LvSLC26a2/7 is also a sulfate transporter 
responsible for the sulfation of PGs. We tested this by performing Alcian blue staining 
using conditions specific for sulfated proteoglycan (SPG) detection. In control embryos, 
Alcian blue staining is strongest in the ventral ectoderm, extending from the posterior to 
the anterior pole, and in the blastopore (Fig. 3.7D). The ventral SPG accumulation 
matches the spatial expression of LvSLC26a2/7 (compare Figs 3.7A and 3.7D). In 
contrast, SLC MO-injected embryos exhibited uniformly low SPG levels (Fig. 3.7G), 
indicating that SLC is required for the ventral SPG accumulation. To corroborate these 
results, we tested the effects of culturing embryos in sulfur-free sea water, or in chlorate-
supplemented sea water. We reasoned that removing external sulfate should phenocopy 
loss of a sulfate transporter; chlorate inhibits the addition of sulfate to the universal 
sulfate donor PAPS, thereby blocking proteoglycan sulfation (Baeuerle and Huttner, 
1986). Previous work showed that sulfated proteoglycans (SPGs) regulate DV 
specification in sea urchin embryos (Bergeron et al., 2011), and consistent with those 




perturbed the DV axis (not shown). To avoid this, we began each treatment at 10 hours 
post fertilization (hpf), after the DV axis is established, but before PMC ingression and 
migration (Bradham and McClay, 2006; Piacentino et al., 2015b). Both treatments 
provoked uniformly low SPG levels, similar to SLC MO (Fig. 3.7E,F). When we 
overexpressed SLC, the embryos displayed uniformly high SPG levels in the ectoderm 
(Fig. 3.7H); this effect was mimicked by culturing embryos in sea water containing 
increased sulfate concentrations (Fig. 3.7I). Due to embryo-to-embryo variability, we 
could not quantitate the Alcian signal across populations; instead, we calculated the 
ventral-to-dorsal signal difference within individuals, then averaged that ratio (Fig. 3.7J). 
The results show that control embryos reproducibly exhibited higher ventral SPG levels, 
while all the treated embryos showed significantly reduced ventral-to-dorsal ratios. These 
results demonstrate that SLC is required to establish ventral SPG accumulation. 
3.4.5 Ventral SPGs are required for ventral skeletal development 
We next examined larval skeletal patterning with our suite of perturbations. Since 
specific skeletal patterning defects varied from pluteus to pluteus, we comprehensively 
scored skeletal patterns in each perturbant, including the presence and absence of each 
rod, defects in rod orientation, and rod transformations or duplications (Fig. 3.10A-C). 
No sulfur, chlorate, and SLC MO each resulted in frequent bilateral loss of the primary 
skeletal elements known as the ventral transverse rods (VTs) (Fig. 3.7L-N,Q; red arrows; 
red elements in schematics). Although other skeletal elements were also perturbed by the 
suite of SPG perturbations, the VTs were more strongly impacted, and were the only 




of the VTs correlated strongly with the occurrence of “midline defects”, referring to 
skeletons with no central elements (Fig. 3.10E). The VTs initially arise along the 
posterior ventral ectoderm at late gastrula stage, coinciding with the location of high SPG 
levels in controls (see Fig. 3.7D and Fig. 3.10A-C). These results indicate that SLC and 
SPGs are required for VT development. High sulfate treatment and SLC mRNA 
injections provoked the development of extra VTs, although at a low frequency (Fig. 
3.7O-P,R). To define the developmental time interval during which SPGs are required for 
skeletal patterning, we performed a treatment timecourse with no sulfur or with chlorate. 
Treatments at 10 hpf resulted in the highest frequency of skeletal patterning defects, and 
the penetrance of this effect sharply decreased during gastrulation (Fig. 3.7S). Treatment 
at 16 hpf resulted in VT defects (not shown), indicating that their patterning occurs 
during gastrulation. These results show that ventral SPGs are required during gastrulation 
for the formation of the VTs. Rescue experiments were performed by co-injection of SLC 
MO and SLC mRNA, and show that exogenous SLC mRNA rescues VT formation in 
morphants (Fig. 3.7T-X), indicating that SLC MO is specific and does not produce off-
target effects.  
3.4.6 Ventral SPGs are necessary and sufficient to attract PMCs ventrally 
We next examined PMC positioning at LG stage with our suite of perturbations. 
As with the skeletal patterning defects, we observed variable PMC positioning defects. 
We therefore established a PMC scoring approach, for which we collected PMC 
coordinates from confocal image stacks, then modeled each PMC’s 3D position. Tbx2/3 




PMCs (Croce et al., 2003b; Gross et al., 2003). We used ectodermal tbx2/3 expression as 
a dorsal landmark to orient each 3D model, and scored each PMC for tbx2/3 expression.  
 SLC MO injection resulted in a significant reduction in the fraction of ventrally-
positioned PMCs (Fig. 3.11Ce, red; 3.11E). Treatment with no sulfur or chlorate 
similarly provoked a significant reduction in ventral PMC positioning (Fig. 3.11Cc,d, E). 
This agrees with previous studies on sulfate-deprived embryos, which exhibited defective 
PMC migration (Katow and Solursh, 1981). Conversely, SLC mRNA provoked a 
significant increase in the fraction of ventrally-positioned PMCs, as did sulfate-
supplemented sea water (Fig. 3.11Cf-g, 3.11E). These results correlate well with the 
skeletal patterning defects, since the PMCs in the ventral ring produce the VTs (see  Fig. 
3.10A-C). Since SPG loss (no sulfur, chlorate, or SLC MO) blocks ventral PMC 
localization and VT formation, while SPG gain (SLC mRNA or high sulfate) promotes 
excessive ventral PMC localization and VT formation, we conclude that ventral SPGs 
provide an attractive cue that is necessary and sufficient for ventral PMC localization and 
VT formation. Thus, SLC is a ventral skeletal patterning gene. 
 During this analysis, we also observed an unexpected change in tbx2/3 expression 
within the PMCs. In control and control MO-injected embryos, almost none of the dorsal 
PMCs are tbx2/3-negative, while surprisingly, SPG loss and gain each provoked a 
striking and significant increase in the percentage of tbx2/3-negative PMCs in the dorsal 
ring (Fig. 3.11D,F). These results indicate that the normal concentration of SPGs is 
required for robust induction of tbx2/3 expression in the dorsal PMCs, while deviations 




3.4.7 Skeletal patterning defects downstream from SPG perturbation do not reflect 
inhibition of VEGF signaling 
To determine if SPG perturbations impact the expression of genes implicated in 
skeletal patterning, we performed qPCR analysis of LG stage embryos with our suite of 
perturbations (Fig. 3.12). Of these, pax2/5/8 expression was upregulated only by sulfur-
free ASW, while changes in Wnt5a and Univin expression were below the threshold for 
significance (Fig. 3.12). However, the expression of vegf and vegfr were increased by 
several of our perturbations (Fig. 3.12). VEGF is an ectodermally expressed signal, and 
VEGFR is expressed by the PMCs, implicating VEGF signaling as a patterning cue 
(Duloquin et al., 2007; Adomako-Ankomah and Ettensohn, 2013b). Spatially, VEGF 
expression appeared similar to controls in SLC MO and SLC mRNA embryos, but was 
increased by no sulfur, chlorate, and increased sulfate (Fig. 3.13A). VEGF expression 
appears to be ventrally expanded in chlorate embryos (Fig. 3.13Ac), despite the lack of 
ventral PMC migration in these embryos (Fig. 3.11). VEGFR expression showed a 
similar profile, appearing normal in SLC perturbants, but abnormal in chemical 
perturbants, with chlorate and no sulfur compressing VEGFR to the PMC clusters, and 
increased sulfate expanding VEGFR to the PMC ring (Fig. 3.13B). It is possible that the 
differences between the SLC perturbants and the chemical perturbants reflect the extent 
of penetrance of their effects. For example, SLC knockdown may not be completely 
effective; moreover, LvSLC26a2/7 is unlikely to be the sole sulfate transporter in the 




should block all PG sulfation; thus each is likely to produce a stronger effect than SLC 
MO. 
 Increased VEGF expression levels likely indicate a compensatory response to 
VEGF signaling inhibition (Adomako-Ankomah and Ettensohn, 2013b), suggesting that 
VEGF signaling requires SPGs. Since SPGs are well known to function as signal 
transduction co-receptors (Baeg and Perrimon, 2000; Sarrazin et al., 2011), we tested the 
possibility that SPG LOF blocks VEGF signaling by comparing the patterning defects 
induced by SLC/SPG LOF and VEGFR LOF, using the VEGFR inhibitor axitinib 
(Bhargava and Robinson, 2011). Axitinib treatment at timepoints prior to 16 hpf blocked 
skeletogenesis; we therefore exposed embryos to axitinib at 16 hpf, then scored their 
skeletal defects at pluteus stage (Fig. 3.13D-F). Axitinib induced an overlapping yet 
distinct profile of skeletal patterning defects in comparison to SLC/SPG perturbation. 
Although it inhibited VTs in approximately 20% of embryos, midway between the effects 
of SLC/SPG loss and gain (Fig. 3.13G), axitinib did not induce midline defects, unlike 
SLC/SPG perturbants (Fig. 3.10E). Unlike SLC/SPG perturbations, axitinib strongly 
impacted the anal rods (ARs) (Fig. 3.13Fa, red elements), which were absent in 100% of 
axitinib-treated embryos (Fig. 3.13Fb,H). This finding is in good agreement with 
previous studies (Adomako-Ankomah and Ettensohn, 2013b). Axitinib also provoked 
frequent misorientation of the body rods (BRs), such that they were approximately 
parallel, rather than converging at the dorsal apex (Fig. 3.13D-F, black elements). This 
reflects an AP rotation defect (Fig. 3.10C), which is the only orientation defect observed 




SLC/SPG perturbations, which provoke a range of orientation defects (Fig. 3.10E). Thus, 
in multiple respects, the skeletal patterning defects in SLC/SPG perturbants are distinct 
from those induced by axitinib. In contrast to these differences, axitinib and SLC/SPG 
perturbation provoked similar losses of the secondary anterior elements (the ORs and 
DAs) (Fig. 3.10D). These results indicate that loss of VEGF signaling does not account 
for the SLC/SPG perturbation-induced ventral skeletal patterning defects, although SPGs 
and VEGF may cooperate in patterning the secondary skeleton. 
3.5 Discussion 
In this study, we hypothesized that Ni and SB mutually regulate ectodermal 
skeletal patterning genes, and that this could be a basis for discriminating patterning 
genes from DV specification genes, which we expected to be reciprocally regulated by Ni 
and SB (Fig. 3.1). We globally identified such candidate genes and functionally tested 
them, and therein demonstrated that our hypothesis was correct. We present several 
novel, validated skeletal patterning genes, and a wealth of candidates to pursue in future 
studies (Fig. 3.2). We also demonstrate that the sulfate transporter LvSLC26a2/7 is 
required to establish ventral SPG accumulation during gastrulation, to attract PMCs 
ventrally, and for development of the ventral transverse (VT) skeletal rods (Figs 3.7 and 
3.11). We observed similar inhibition of PMC migration and VT development by 
blocking either sulfur uptake with sulfur-free sea water or proteoglycan sulfation with 
chlorate. Conversely, SLC overexpression or high sulfate treatment led to increased 
global SPGs, excessive ventral PMC migration and, in some cases, the production of 




skeletal patterning strengthen the conclusion that SLC-dependent SPGs provide a cue that 
directs PMCs ventrally and patterns the ventral transverse skeletal elements.   
Sulfated proteoglycans are critical regulators of signaling and cell migration 
during development (Iozzo and Schaefer, 2015) and metastasis (Cattaruzza and Perris, 
2005; Theocharis et al., 2010). In some cases, SPGs function by presenting signaling 
ligands to their receptors. For example, in the zebrafish lateral line primordium, SPGs 
promote FGF signaling during collective cell migration (Venero Galanternik et al., 2015). 
In other cases, SPG receptors directly bind SPGs to regulate cell migration (Lang et al., 
2015; Neill et al., 2015). In sea urchin embryos, SPGs have been previously implicated as 
regulators of PMC migration in vitro and in vivo (Karp and Solursh, 1974; Katow and 
Solursh, 1981; Katow, 1986a; Solursh et al., 1986; Solursh and Lane, 1988), and as 
regulators of skeletal patterning (Sakuma et al., 2011). These results corroborate our 
findings, which independently identify SLC-dependent SPGs as a ventral skeletal 
patterning cue via an unbiased screen.  
 The sea urchin sulfatase HpSulf, while lacking a GOF effect alone, suppresses the 
radializing effects of VEGF overexpression, suggesting that SPGs facilitate VEGF 
signaling (Fujita et al., 2010). VEGF signals locally in sea urchin embryos (Duloquin et 
al., 2007), consistent with SPGs spatially retaining VEGF through binding. Our results 
suggest that SPGs and VEGF cooperate during sea urchin skeletal patterning, although 
their functions do not completely overlap. It seems likely that the primary VT elements 
are patterned by SPGs in a VEGF-independent manner (Fig. 3.14), since VEGFR 




not normally coincide spatially with the VTs (Fig. 3.13). However, VEGFR and SPG 
inhibition each impair secondary skeletal patterning (Fig. 3.13, Fig. 3.10), as does 
inhibition of LvUnivin (Piacentino et al., 2015b). It thus seems likely that SPGs, VEGF, 
and Univin cooperate to direct secondary PMC migration (Fig. 3.14). VEGF knockdown 
increases VEGF expression in an apparently compensatory response (Adomako-
Ankomah and Ettensohn, 2013b). Such a feedback circuit would minimally involve a 
second signal downstream from VEGFR in the PMCs back to the ectoderm that normally 
functions to dampen VEGF expression. Thus, the elevated VEGF expression levels 
provoked by chlorate or no sulfur imply a loss of VEGF signaling, and suggest that SPGs 
are required for VEGF signaling. Interestingly, treatment with high sulfate also elevated 
VEGF expression, similarly implying that VEGF signaling is inhibited. Obtaining similar 
results with both SPG gain and loss could reflect a scaffolding function for SPGs, in 
which they jointly present VEGF and a second required factor to solicit VEGF signaling. 
In the absence of SPGs, the signal and factor would not be co-presented, while excessive 
SPGs levels could bind the signal and factor independently, and fail to co-present them. 
Since VEGF, Univin and SPGs are required for secondary skeletal patterning, we 
hypothesize that SPGs scaffold VEGF and Univin, co-presenting them to the PMCs to 
promote secondary migration (Fig. 3.14). It is possible that these combined signals are 
reflected in the feedback to VEGF expression.  
 We also found that SPG loss suppresses Tbx2/3 expression in the dorsal PMCs 
(Fig. 3.11). This result might imply that the Tbx-negative PMCs that did not migrate 




also suppressed dorsal Tbx2/3 expression while concomitantly increasing the number of 
ventral Tbx-negative PMCs, arguing against that conclusion. Our results show that dorsal 
Tbx2/3 expression requires ventral SPGs but is also suppressed by their excess (Fig. 
3.11), again suggesting a scaffolding role for ventral SPGs in mediating dorsal Tbx2/3 
expression in the PMCs. This is an unexpected result, since the known ectodermal 
Tbx2/3 inducers are dorsal genes or signals (Su et al., 2009a; Saudemont et al., 2010b); 
however, little is known about the regulation of PMC-specific Tbx2/3 expression. We 
note that inhibition of ventral specification in Lv embryos results in radial Tbx2/3 
expression (data herein and (Piacentino et al., 2015b)), suggesting that ventral signals 
locally suppress LvTbx2/3, which is otherwise globally induced.  
 This study identifies novel ectodermal cues for patterning the sea urchin larval 
skeleton, and for the first time, identifies a cue that specifically patterns an element of the 
primary skeleton. It will be interesting to extend this study to our additional candidates 









Figure 3.1 Ectodermal p38 inhibition results in skeletal patterning defects and 
blocks ventral ectodermal specification. A. Morphology (Aa) and skeletal 
birefringence (Ab) of a sea urchin embryo treated with SB203580 (SB) prior to 
gastrulation. B. Schematic depicting PMC transplants, with rhodamine-labeled donor 
PMCs transplanted into unlabeled recipient ectodermal hulls at mesenchyme blastula 
stage. C-D. Morphology (Ca,Da), skeletal pattern (Cb,Db), and PMC positioning (Cc,Dc) 
is shown for chimeras in which only the donor PMCs (C) or the recipient hull (D) were 
exposed to SB. E-F. PMC-specific immunostaining shown in control (E) and SB (F) 
embryos at early (Ea,Fa), mid (Eb,Fb), and late gastrula (Ec,Fc) stages (14, 16, and 18 
hpf, respectively). G-H. Whole mount in situ hybridization for ventrally expressed nodal 
(G) and dorsally expressed tbx2/3 (H) in control (Ga,Ha), Ni (Gb,Hb), and SB (Gc,Hc) 
embryos at late gastrula stage. I. The dorsal-ventral ectoderm boundary is shown by 
ciliary band-specific immunostaining in control (Ia), Ni (Ib), and SB (Ic) pluteus stage 









Figure 3.2 A differential RNA-Seq-based screen identifies skeletal patterning genes 
in the sea urchin embryo. A. Schematic representation of the rationale for the screen 
employed herein. B. Box plots depicting the range of expression values following 
normalization of RNA-Seq data. C-D. Pie charts display differential analysis results from 
the final RNA-Seq assembly. From the mutually downregulated set of scaffolds (C, red), 
the intra- and extracellular localization of the identifiable subset is shown (D). E-F. 
Differential expression values are shown in MA plots for Ni (E) and SB (F) compared 
with control. Mutually upregulated (red) and downregulated (blue) scaffolds are shown. 
Validated skeletal patterning candidates and other genes implicated in skeletal patterning 
are indicated. G. iPAGE analysis showing enrichment of GO terms as a heat map with 
bins reflecting the range of ratios of the average gene expression in Ni and SB embryos 
compared to control expression. Mutually downregulated bins are to the left, and 
mutually upregulated bins are to the right. H-L. Loss-of-function analysis for four 
skeletal patterning candidate genes is shown as morphology (DIC; H), skeletal pattern (I), 
PMC immunostaining at late gastrula stage (18 hpf; K) and PMC (J) and ciliary band (L) 
immunostaining at pluteus stage (48 hpf), for embryos injected with the indicated MO. 
Corresponding phase contrast images are displayed as insets. The pluteus stage PMC 






Figure 3.3 Identification of skeletal patterning candidates by differential analysis of 
RNA-Seq data and expression analysis of known specification, differentiation, and 




analysis from the initial assembly. From the mutually downregulated set (A; red), the 
subcellular distribution of the identifiable subset is shown (B). C. RNA-seq expression 
values from the final assembly are shown relative to controls for the four candidate 
skeletal patterning genes described in Fig. 3.2. D-H. RNA-seq expression values from the 
final assembly are shown relative to controls for genes specifically expressed in the 
ventral ectoderm (D), the dorsal ectoderm (E), the endoderm (F), the skeletogenic 
primary mesenchyme cells (PMCs; G), and the secondary mesenchyme cells (SMCs; H). 
I-J. Differential RNA-seq expression values for 372 sea urchin metabolic network 
components were mapped using iPath 2.0. Increased (green) and decreased (red) gene 
expression at a 4-fold cut-off is shown for Ni (I) and SB (J) at late gastrula stage 






Figure 3.4 Morpholino design and phylogenetic analysis for four identified skeletal 
patterning candidate genes. A. The designs for morpholino antisense oligonucleotide 
(MOs) sequences are shown for six skeletal patterning candidate genes. Three MOs are 
designed to block mRNA splicing (SLC, BMP5-8, and NFL), while one is designed to 
block translation (LOX). Untranslated sequences are indicated in red. B-E. Phylogenetic 
analysis for SLC (B), NFL (C), BMP5-8 (D), and LOX (E) are shown as distance trees 




in red. Species included are echinoderm: Lv, Lytechinus variegatus; Sp, 
Strongylocentrotus purpuratus; vertebrate: Hs, Homo sapiens; Mm, Mus musculus; Rn, 
Rattus norvegicus; Oc, Oryctolagus cuniculus; Gg, Gallus gallus; Xt, Xenopus tropicalis; 
Dr, Danio rerio; Bt, Bos taurus; Lc, Latimeria chalumnae; Tg, Taeniopygia guttata; 
invertebrate chordate: Ci, Ciona intestinalis; Cs, Ciona savignyi; and arthropod: Dm, 









Figure 3.5 Skeletal patterning gene MOs are specific. A. Penetrance of SLC, NFL, 
BMP5-8 and LOX MOs as determined by percent of phenotypic embryos. B-D. Rescue 
experiments were performed for NFL (D), BMP5-8 (E), and LOX (F). Exemplar 
phenotypes are shown for control, LOF, GOF and rescued plutei by DIC (upper panels) 
and skeletal images (lower panels), and quantitated to determine reproducibility (De, Ee, 
Fe). MO and mRNA doses for rescued plutei are indicated in the graphs. See Figure 
3.7T-Y for SLC MO specificity controls. E-G. Splice analysis for control, SLC MO- 
(1.33 mM; E), NFL MO- (1 mM; F), and BMP5-8 MO-injected (2 mM; G) embryos at 
LG stage, showing an amplicon upstream the MO target site (“positive control”) and 







Figure 3.6 Sequence analysis indicates that LvSLC26a2/7 is most similar to 
vertebrate SLC26a2 and SLC26a7 genes. A. LvSLC26a2/7 conserved domains include 
Sulf Gly (sulfate transporter N-terminal domain with GLY motif, red), Sulfate 
Transporter Family (green), and STAS (sulfate transporter and anti-sigma factor 
antagonist, blue). Predicted transmembrane domains are indicated as dark grey boxes. 
Amino acid numbers above and below the schematic indicate domain boundaries. B. 




SLC26a7 translations are displayed with conserved domains boxed, following the color 









Figure 3.7 LvSLC26a2/7-dependent ventral sulfated proteoglycans are required for 
the formation of the ventral transverse skeletal elements. A. Spatial expression of 
slc26a2/7 (red) and ventral marker chordin (green) is shown at late gastrula stage in 
posterior (Aa) and lateral (Ab) views. Corresponding DIC images are inset. B. Relative 
temporal expression of slc26a2/7 is displayed as normalized ∆CT values at 11 
developmental timepoints ranging from egg to pluteus stages, as average ± SE. C. 
slc26a2/7 expression levels in Ni and SB embryos compared to controls at late gastrula 
stage is shown as average ± SE. D-I. Alcian blue staining of sulfated proteoglycans at 
late gastrula stage with the indicated treatments, shown in posterior (upper panels) and 
lateral (lower panels) views. Images were pseudocolored using the indicated LUT to 
highlight differences in staining intensity. J. Relative Alcian blue staining is displayed as 
the ratio of ventral/dorsal staining intensity in control and perturbed embryos, and is 
shown as average ± SE; *p<0.05, **p<0.005, ***p<0.0005 compared to control; n ≥ 10 
for all conditions. K-P. Pluteus stage (48 hpf) morphologies and skeletal patterns are 
shown for the indicated treatments. The lower panel shows skeletal schematics, with the 
ventral transverse (VT) elements indicated in red. Filled or open red arrows indicate VT 
presence or absence, respectively. Q-R Quantitation of the frequency of VT loss (Q) and 
gain (R) with the indicated treatments. S. Quantitation of the fraction of phenotypic 
embryos resulting from treatment timecourses with no sulfur or chlorate. T-W. 
Morphology and skeletal patterns for embryos injected with SLC MO (U), mRNA (V), or 




respectively. X. Quantitation of VT loss in the SLC rescue experiments. The SLC MO 









Figure 3.8 LvSLC26a2/7 expression is suppressed in sea urchin embryos treated 
with Ni or SB. Fluorescent in situ hybridization for slc26a2/7 (slc, A-D, red) and either 
ventrally-expressed chordin (chd) (A-B, green), or dorsally-expressed tbx2/3 (C-D, 
green) in untreated (A) or vehicle-treated (DMSO; C) controls, or in Ni- (B) or SB- (D) 
treated embryos at late gastrula stage, in posterior views (pv; Aa,Ba,Ca,Da) and lateral 






Figure 3.9 Alcian blue and Curpolinic acid staining highlights ventral SPG 
accumulation in control embryos. Control embryo (A,C) and embryo cultured in sulfur 
free sea water (B,D) at LG stage were stained with Alcian blue (A,B) under SPG-specific 
conditions, or with Cuprolinic acid (C,D). Raw images (a) were converted to grayscale 




(insets) was applied (c). The dorsal-ventral axis is indicated. Note that the fixation 









Figure 3.10 Skeletal scoring analysis highlights significant skeletal patterning 
defects in sea urchin embryos. A. Schematic displaying the primary skeleton at late 
gastrula stage. The initial triradiates (dark blue) in the ventrolateral PMC clusters extend 
into the ventral PMC ring to produce the ventral transverse rods (VTs), into the PMC 
cords to produce the dorsoventral connecting rods (DVCs), and laterally to produce the 
anonymous rods (anon), which extend only slightly before branching. The primary 
skeletal elements (light blue) also include the body rods (BRs), which branch from the 
anonymous rods and extend into the dorsal PMC ring. The anus (a) is indicated. B. 
Schematic depicting the skeleton at pluteus stage. Here, the secondary skeleton is 
indicated in red, and includes the posterior anal rods (ARs), which branch ventrally from 
the anonymous rods, the posterior scheitel (sch), which branches from the dorsal tips of 
the body rods, and the anterior oral rods (ORs) and recurrent rods (RRs), which branch 
from the dorsoventral connecting rods (DVCs). Production of the secondary skeleton 
requires PMC migration out of the initial ring-and-cords pattern. The anus (a) and mouth 
(m) are indicated. C. We developed a skeletal patterning scoring rubric, which included 
scoring losses and gains for the elements shown in B, as well as a range of additional 
defects including left and right side-biased losses, midline defects, spurious elements, 
element transformations, and skeletal orientation defects. We classified orientation 
defects as rotations about the anterior-posterior (Ca), dorsal-ventral (Ca), or left-right 
(Cb) axis. Some embryos exhibited more than one orientation defect. Midline defects are 
defined as the absence of skeletal elements from the left-right midline of the pluteus (i.e., 




present where no element would normally develop, while gained element refers to 
duplications of normal rods. For rotational defects, embryos were counted if at least one 
element was appropriately perturbed, while LR defects were counted for an LR 
imbalance of at least two rods. In cases where the presence of an element was ambiguous 
because of the orientation of the embryo, we assumed the element was present. D-E. The 
frequency of skeletal patterning defects, with left (L) and right (R) side elements scored 
independently for pluteus stage larvae following SLC/SPG perturbation (no S, Chlorate, 
SLC MO, SLC mRNA, high Sulfate) or VEGF inhibition (Axitinib). Skeletal losses (D) 
and additional defects (E) are shown. Data are depicted as the percentage of embryos 
exhibiting each defect. Sample sizes are: no S, 62; chlorate, 38; SLC MO, 81; axitinib, 
30; SLC mRNA, 47; high sulfate, 46. Fig. 3.7 and Fig. 3.13 depict selected portions of 
these results. Uninjected controls (n=34) and GST MO-injected controls (n=18) show 









Figure 3.11 SPGs are necessary and sufficient to attract PMCs ventrally. A-B. PMC 
positions (A-B; red) and dorsal tbx2/3 expression (B; green) are shown in late gastrula 
stage embryos with the indicated treatments. C-D. PMC models reflecting 3D 
coordinates extracted from image data and tbx2/3 expression scores are shown to depict 
the PMC domains (C) and tbx2/3 expression within the PMCs (D). E-F. Quantitation of 
the fraction of ventral PMCs (E) and the fraction of dorsal ring tbx2/3-negative PMCs per 
embryo (F), shown as the average percentage ± SE; *p<0.05, **p<0.01, ***p<0.001, n.s. 






Figure 3.12 SPGs are necessary and sufficient to attract PMCs ventrally. A-B. PMC 
positions (A-B; red) and dorsal tbx2/3 expression (B; green) are shown in late gastrula 
stage embryos with the indicated treatments. C-D. PMC models reflecting 3D 
coordinates extracted from image data and tbx2/3 expression scores are shown to depict 
the PMC domains (C) and tbx2/3 expression within the PMCs (D). E-F. Quantitation of 
the fraction of ventral PMCs (E) and the fraction of dorsal ring tbx2/3-negative PMCs per 
embryo (F), shown as the average percentage ± SE; *p<0.05, **p<0.01, ***p<0.001, n.s. 






Figure 3.13 SPG perturbations elicit skeletal patterning defects that are distinct 




shown in late gastrula stage control embryos and in embryos following the indicated 
LvSLC/SPG perturbations. qPCRs are shown in Figure 3.12. D-F. Morphology (D), 
skeletal patterns (E), and schematics (F) for control plutei (Da,Ea,Fa) and plutei 
developed from embryos treated with axitinib at 16 hpf (Db,Eb,Fb). The schematics 
emphasize the anal rods (ARs, red). G-H. Skeleton scoring analysis scores comparing 
SLC/SPG perturbations with axitinib treatment are shown for the VTs (G) and the ARs 









Figure 3.14 Model for SLC-mediated skeletal patterning. A. In gastrulating embryos, 
SLC mediates the ventral accumulation of SPGs, which in turn are necessary for the 
ventral positioning of PMCs and subsequent formation of the primary ventral transverse 
rods (red). Anterolateral SPGs may function to coordinate the presentation of laterally 
expressed Univin and VEGF signaling ligands to nearby PMCs to induce their secondary 
migration (blue). B. Schematic representation of the function of SLC and SPGs at the 
cellular level in ventral PMC attraction in control (Ba), SPG loss (Bb), and SPG gain 





Table 3.1 Perturbation timing and dose information 
Perturbation (Vendor) Stage (hours-post-
fertilization) 
Dose Range 
NiCl2 (Sigma) Zygote to 12 hpf 0.3 mM – 0.5 mM 
SB203580 (Calbiochem)  Zygote to 12 hpf 25 µM – 30 µM 
LvSLC26a2/7 MO 
(GeneTools)  
Zygote 1.33 mM – 2.67 mM 
LvSLC26a2/7 mRNA Zygote 1.25µg/µL – 4 µg/µL 
LvNFL MO (GeneTools) Zygote 1mM–2mM  
LvBMP5-8 MO (GeneTools) Zygote 0.5mM–1.33mM  
LvLOX MO (GeneTools) Zygote 0.53mM–0.8mM  
LvSVEP MO (GeneTools) Zygote 2mM–2.67mM  
LvST14 MO (GeneTools) Zygote 0.67mM–1mM  
Control MO (GeneTools) Zygote 1mM  
Sulfur-free artificial sea water 10 hpf 0 mM magnesium sulfate  
Sodium chlorate (Sigma) 10 hpf 10mM–30mM 
High sulfate artificial sea 
water 
10 hpf 68 mM – 100 mM sodium 
sulfate  






Table 3.2 Primer sequences 
Primer Sequence (5’ --> 3’) Use 
LvSLC26a2/7 
forward  
TAGATGATCGAACGGAGGACC  cloning 
LvSLC26a2/7 
reverse  
CAATCCAATTAAGGGTTTCGAGTTGTTTGC  cloning 
LvSLC26a2/7 5’ 
UTR BamHI  
atcaaggatccCAGTGCCATGGACCACTGGATTGCa  cloning 
LvSLC26a2/7 3’ 






TCCCTGTTGGA TTTCCCAAAC  qPCR 
LvSLC26a2/7 
reverse  
CACTGCAAAGCCCACAATAGC  qPCR 
LvVEGF forward  CTACAAAGGAAGGCGGAACG  qPCR 
LvVEGF reverse  GCTCCGTTGATACATGGTGG  qPCR 
LvVEGFR forward  CCACCA TCACCCATCAAACCACC  qPCR 
LvVEGFR reverse  CCCTGACCTGAATCCACTGG  qPCR 
LvPax2/5/8 forward  CGGCTGTTGGCCGAGGGTGTGTGC  qPCR 
LvPax2/5/8 reverse  CGTCCTCTCTGGGTCTCCAGGGTG  qPCR 
LvWnt5a forward  CGAGCTCTTCATCCTTGGTACA  qPCR 
LvWnt5a reverse  TGGTCCTGGTAGAGCTGACATA  qPCR 
LvUnivin forward  CAAA TGGCAGCAACAGAAGA  qPCR 
LvUnivin reverse  GGAATGGAAGCTACGTCGAA  qPCR 
LvSetmar forward  GCCA TCA TGTCCTTGTCTCA  qPCR 
LvSetmar reverse  CACATGAAGCTTGATCAGGTAGTC  qPCR 
aUpper case indicates gene-specific sequence, while lower case indicates artificial polyA 






















 Understanding the mechanisms that regulate embryonic morphogenesis remains 
a central goal for the field of developmental biology. Morphogenesis of the sea urchin 
larval skeleton is a useful model to pursue this question, since sea urchin skeletogenesis 
is comparatively simple, involving only two major cell types. Skeleton formation is a 
coordinated process in which skeletogenic primary mesenchyme cells (PMCs) migrate, 




This reproducible set of events is well established, but our understanding of the molecular 
and cellular underpinnings of pattern formation remains incomplete. In this study, we 
demonstrate a novel role for sea urchin lipoxygenase (LOX) in regulating embryonic 
skeletal patterning. Mammalian 5-LOX is expressed primarily by cells in the immune 
system, and deletion of the 5-LOX gene modulates the immune response without causing 
developmental defects. In contrast, sea urchin embryos in which LOX expression is 
perturbed exhibit dramatic skeletal patterning defects that are accompanied by defects in 
PMC positioning, connectivity, and gene expression. Our results are consistent with a 
model in which LOX mediates these effects through three distinct downstream 
mechanisms. Together, these data demonstrate a novel and unexpected role for 5-LOX in 
developmental pattern formation. 
4.2 Introduction 
The mechanisms underlying pattern formation and morphogenesis during 
embryonic development remains an important open question. The sea urchin skeleton 
offers a simple model to interrogate embryonic pattern formation, in which migratory, 
skeletogenic primary mesenchyme cells (PMCs) are directed to arrange into a distinctive 
three-dimensional (3-D) configuration in response to patterning cues expressed by the 
ectodermal hull (Lyons et al., 2012). The skeletogenic PMCs thus translate patterning 
information from the ectoderm into the morphogenetic movements that in turn define the 
shape of larval endoskeleton. The PMCs are specified at the posterior pole of the embryo, 
individually ingress into the blastocoel, then migrate into a stereotypic initial pattern 




composed of a posterior ring of cells with two ventrolateral clusters (VLCs) that each 
extend a chain of PMCs anteriorly, forming two PMC cords. This primary "ring-and-
cords" arrangement defines the formation and pattern of the primary skeleton (Lyons et 
al., 2012). During their primary migration, PMCs extend pseudopodia that contact those 
on neighboring PMCs and fuse to create syncytial tubes into which the skeleton is 
secreted (Okazaki, 1960; Ettensohn and Dey, 2017). Biomineral secretion by the PMCs is 
initiated in the VLCs to form triradiate structures, which then extend, following the 
primary pattern of PMC positioning. As skeletogenesis progresses, the PMCs migrate out 
of this primary pattern, again in a very stereotypical manner, to mediate the patterning 
and formation of secondary skeletal elements (Malinda and Ettensohn, 1994; Piacentino 
et al., 2015a; Piacentino et al., 2016b).  
The spatial positioning of PMCs is directed by the overlying ectoderm (Lyons et 
al., 2012). This relationship was first hypothesized by von Ubisch (von Ubisch, 1937) 
and later demonstrated by Wolpert and Gustafson and others. Treatments which 
selectively affected ectodermal specification (Wolpert and Gustafson, 1961b) and 
subsequent PMC-transplantation experiments combined with ectodermal perturbation 
(Armstrong et al., 1993) clearly demonstrated that PMC positioning and skeletal 
morphogenesis are directed by cues that originate in the ectoderm. More recent studies 
have identified ectodermal gene products that regulate skeletal and PMC patterning, 
including transcription factors (Di Bernardo et al., 1999; Cavalieri et al., 2003a; Cavalieri 
et al., 2011), fibroblast- and vascular endothelial growth factors (Duloquin et al., 2007; 




containing signal Strim1 (Cavalieri et al., 2011) and Wnt5a (McIntyre et al., 2013b). 
Each of these factors is expressed by the ectoderm in restricted domains adjacent to 
PMCs that are actively secreting skeletal biomineral, and each is required for 
biomineralization (Cavalieri et al., 2003a; Duloquin et al., 2007; Rottinger et al., 2008; 
Adomako-Ankomah and Ettensohn, 2013a; McIntyre et al., 2013b), such that knockdown 
embryos lack skeletons entirely; it is thus difficult to define the specific contribution that 
each of these factors might provide for skeletal patterning. At that point, no cues had 
been identified that are specifically responsible for patterning defined regions of the 
skeleton. 
We therefore performed an RNA-seq based screen to identify novel ectodermal 
patterning cues, and thereby discovered numerous genes that are required for normal 
PMC positioning and skeletal patterning (Piacentino et al., 2016a; Piacentino et al., 
2016b). Importantly, for each of the validated patterning cues discovered in our screen, 
their loss-of-function (LOF) does not generally block biomineralization, but instead 
elicits specific and distinct PMC positioning and skeletal patterning defects that likely 
reflect the loss of local ectoderm-PMC patterning interactions (Piacentino et al., 2015a; 
Piacentino et al., 2016a; Piacentino et al., 2016b). 
Of the hundreds of genes that we identified as candidates, the lipoxygenase enzyme, 
LvLOX, was the second most consistent hit in that screen, and we validated it as a 
skeletal patterning gene (Piacentino et al., 2016b). Lipoxygenases are well-studied 
enzymes that are expressed primarily by cells in the mammalian immune system, where 




migration to sites of injury and inflammation (Haeggstrom and Funk, 2011; Powell and 
Rokach, 2015; Basil and Levy, 2016). Lipoxygenase gene deletion modulates immune 
responses but does not provoke developmental defects (Chen et al., 1994; Doepping et 
al., 2007; Powell and Rokach, 2015); thus, a developmental role for lipoxygenase 
enzymes has not been previously described. Lipoxygenase expression is also observed in 
some tumors, in which it plays a pro-proliferative role, although the relationship between 
LOX activity and tumorigenesis is complex and incompletely understood (Pidgeon et al., 
2007). Here, we extend our previous findings (Piacentino et al., 2016b) to show that 
LvLOX activity is required to regulate local PMC positioning, ventral skeletal patterning 
and bilateral skeletal registry, and to repress pks2 expression within the PMCs. We 
propose a model to integrate these results. Together, these findings define a novel 
developmental role for lipoxygenase activity in developmental pattern formation. 
4.3 Materials and methods 
 
4.3.1 Animals, perturbations, and reagents 
 
Adult Lytechinus variegatus sea urchins were obtained from the Duke University 
Marine Laboratory (Beaufort, NC) or from Reeftopia (Miami, FL). Gamete harvesting, 
embryo culturing, and microinjection were performed as described (Bradham and 
McClay, 2006). Morpholinos were purchased from GeneTools. The sequence of the 
control MO and LOX MO have previously been reported (Piacentino et al., 2016b). The 
sequence of pks2 MO is 5’-TAGCTCCCTTCCAACTATCGTCCAT-3’. Injected 
mRNAs were in vitro transcribed using the mMESSAGE mMACHINE kit (Ambion). 




ml cultures in 24 well plates. 5(S)-HETE was concentrated 10x to 1000 µg/µL under a 
nitrogen stream prior to use to limit solvent bioincompatibility. Fibronectin (Invitrogen) 
was diluted to 10 µg/mL in 0.1 mM NaHCO3 prior to use. 
4.3.2 Embryo imaging and skeletal image analysis 
 
Differential interference contrast (DIC) was used to capture embryo morphology, 
and larval skeletal birefringence was imaged using plane-polarized light, on a Zeiss 
Axiovision microscope using 200X magnification. Skeletons were captured in multiple 
focal planes, which were manually recombined into montage images using Canvas (ACD 
Systems) to present the complete larval skeleton in focus for clarity. The full set of 
skeletal images was used for scoring to clearly discriminate left and right halves; scoring 
was performed using our in-house rubric (Piacentino et al., 2016b). The ImageJ line ROI 
tool was used to measure the angles between skeletal halves. Line ROIs were drawn over 
the length of the aboral and body rods in images of prone embryos and the angle between 
each ROI was measured in individuals.  
4.3.3 Immunofluorescent labeling and confocal microscopy 
 
Immunolabeling was performed as described (Bradham and McClay, 2006; 
Piacentino et al., 2015a). Primary antibodies include PMC-specific 6a9 (1:3; the kind gift 
of Dr. Charles Ettensohn, Carnegie Mellon University, Pittsburg, PA, USA), ciliary band-
specific 295 (undiluted; the kind gift of Dr. David McClay, Duke University, Durham, 
NC, USA), and anti-serotonin (1:500, Sigma # S5545). Secondary antibodies were goat 
anti-mouse Cy3 (1:500; Jackson Laboratories) and goat anti-mouse Alexa Fluor 488 




microscope at 10X or 60X magnification. Confocal z-stacks were projected using 
ImageJ; all fluorescent images are full projections of confocal z-stacks unless otherwise 
noted.  
4.3.4 Immunostainng and confocal microscopy 
 
 The riboprobes include full-length LvLOX (Piacentino et al., 2016b), LvTbx2/3 
(Gross et al., 2003), LvChd (Bradham et al., 2009), and partial length LvPks2 (GenBank 
accession number MT274579), LvCan1 (Supplemental Text A) and LvJun (Supplemental 
Text B); riboprobes were labeled with DNP-11-UTP (PerkinElmer) or digoxigenin-UTP 
(DIG, Roche). Probe details are available upon request. Fluorescent in situ hybridization 
was performed as described (Bradham et al., 2009; Piacentino et al., 2015a). FISH using 
PMC-specific probes (LvTbx2/3, LvPks2, LvCan1, LvJun) was followed with fluorescent 
immunolabeling as described above with Hoechst33258 (1:1000, Sigma) nuclear labeling 
for confocal microscopy and subsequent spatial mapping. Gene expression was scored 
manually from confocal z-stacks, then binned into no/low/medium/high expression levels 
for pks2, and on/off binary bins for can1 and jun, then also binned into consecutive 
adjacent spatial territories (for inter-embryo comparisons, since PMC positions are not 
identical between individuals). Spatial territories were defined depending on 
developmental stage, and typically include 2-3 PMCs (Fig. 4.12C). Normalized, indexed 
values for gene expression were then averaged across individuals on a per-territory basis. 
4.3.5 3D PMC modeling and analysis 
 
ImageJ was used to manually process confocal z-stack images of immunolabeled 




sets were mapped to 3-D space using Blender 2.75 (www.blender.org) (Zuch and 
Bradham, 2019). For domain assignments, PMCs were defined as belonging to a cluster 
if they contacted more than two other PMCs. PMC spacing was calculated as Euclidian 
3-D distance between manually collected cell centroids using SciPy in Python 2.7. PMCs 
flanking the ends of PMC chains were included to measure spacing across the full linear 
domain. Skeletal elements were measured similarly; endpoints of individual skeletal 
elements were assigned manually from confocal z-stack images using ImageJ. Endpoints 
were defined as either the end of a skeletal element, or the point where an element 
branches. Rod lengths were calculated as above using SciPy in Python. Triradiate angle 
measurements were calculated using the distal endpoints of triradiate elements. The 
normal vector of the plane for each triradiate was calculated in Matlab as the cross 
product between two lines passing through the three endpoints. The normal vector of the 
left-right midline plane was defined as the line connecting left and right triradiate 
centroids. The triradiate rotation angle was defined as the complement of the angle 
between the triradiate normal vector and the midline normal vector. 
4.3.6 In vitro PMC migration assays  
PMCs were induced via injection of SpPmar1 mRNA (500 ng/µL) (Oliveri et al., 
2003), then collected upon transformation (approximately 12 hpf). The cells were then 
plated in Boyden chambers (Cell Biolabs #CBA-105) with a 5 µm pore size that were 
coated with fibronectin (10 µg/mL). PMCs were allowed to migrate for 8 hours at RT. 





4.3.7 qPCR analysis 
cDNA preparation and qPCR analysis were performed as described (Piacentino et 
al., 2015a). qPCR primer sequences are provided in Table 4.1.  
4.3.8 PMC preparation and FACS sorting for single cell RNA-seq analysis 
Embryos were disaggregated according to (McClay and Fink, 1982), with 
modification as follows: Approximately 2000 embryos at 18 hpf were collected in 
artificial seawater (ASW) with pronase (0.66 mg/mL, Sigma) and immediately 
centrifuged for 1 min at 800xg, then resuspended in calcium-free sea water (CFSW: 450 
mM sodium chloride, 9 mM potassium chloride, 48 mM magnesium sulfate, 6 mM 
sodium bicarbonate) containing 20 mg/mL BSA, followed by the addition of 1 volume of 
hyaline extraction medium (HEM) (McClay and Fink, 1982) and allowed to incubate for 
4 min at room temperature (RT). Embryos were then centrifuged for 1 min at 800xg, 
resuspended in CFSW, triturated with decreasing diameter pipettes for 30 seconds total, 
then centrifuged at 1000xg for 2 minutes to pellet dissociated cells. Single cells were then 
resuspended in CFSW, centrifuged for 1 min, then resuspended in 1mg/mL BSA in ASW 
with 6a9 antibody (1:5) and anti-mouse Alexa-fluor488 (1:500) and incubated in the dark 
for 5 min at RT. Following washes, cells were suspended in CFSW containing Sytox 
Blue Dead Cell Stain (1:1000, ThermoFisher) to label dead cells for exclusion, then 
sorted using a Sony SH800 Cell Sorter. Cells were gated to exclude doublets and dead 
cells and collected into 96-well plates (preloaded with RNA lysis buffer) at one cell per 
well, then held at -80°C until processing for single cell library preparation. 











































4.4.1 Lv5-Lipoxygenase (LvLOX) is a skeletal patterning cue 
 
In Chapter Three, we identified LvLOX as a skeletal patterning cue in the sea 
urchin Lytechinus variegatus (Piacentino et al., 2016b). Here we extend those results, and 
similarly find that LvLOX is required for normal skeletal patterning. LvLOX is expressed 
before and during larval skeletogenesis (Fig. 4.2), and zygotic microinjection of a 
morpholino targeting of LvLOX translation (Piacentino et al., 2016b) produces plutei 
with severe perturbations of their skeletal organization. These embryos exhibit a suite of 




(VTs, ventral transverse rods) and an absence of elements in the bilateral midline, often 
accompanied by a rotation of the left and right skeletal halves about the anterior-posterior 
embryonic axis (AP rotation) (Fig. 4.1A; 4.3A-B). These results indicate that LvLOX is 
required for ventral and midline skeletal patterning, and for the normal AP orientation of 
each half skeleton. 
We next assessed the effects of LvLOX gain-of-function (GOF) via zygotic 
microinjection of LvLOX mRNA. We found that global LOX expression elicits specific 
losses and defects in dorsal skeletal elements (Fig. 4.1B, BRs, body rods). In contrast to 
LOX inhibition, LOX mRNA injection provoked comparatively few ventral defects (Fig. 
4.3B). These results indicate that global expression of LOX is sufficient to induce dorsal 
skeletal patterning defects.  
In mammals, three distinct LOX isoforms, 5-, 12- and 15-LOX, convert 
arachidonic acid into three functionally distinct hydroxyeicosatetraenoic acids, 5(S)-
HETE, 12(S)-HETE, and 15(S)-HETE respectively, each of which activates G-protein-
coupled receptors that in turn activate various signal transduction pathways (Fig. 4.3C) 
(Pidgeon et al., 2007). Phylogenetic analysis of LvLOX was not sufficient to resolve its 
closest vertebrate ortholog (Piacentino et al., 2016b); we therefore used comparative 
pharmacological analyses to functionally classify LvLOX. We treated embryos with 
pharmacological inhibitors of 5-, 12- and 15-LOX (Fig. 4.3C), then compared the 
resulting phenotypes with morpholino-mediated LvLOX knockdown (Fig. 4.3D-E). 
MK886 blocks 5-LOX activity via inhibition of its required activator FLAP (5-LOX 




treatment were most similar to those provoked by LOX MO, including the losses of 
specific elements and skeletal orientation defects (Fig. 4.1A, 4.3D-E). 12-LOX inhibition 
by Baicalein (Deschamps et al., 2006) also provoked skeletal patterning defects, and 
although the defects were partially overlapping with those elicited by MK886, they are 
clearly distinct from those displayed by LvLOX morphants, particularly with regard to 
rotational defects (Fig. 4.3D-E). 15-LOX inhibition via PD146176 (Nair and Funk, 2009) 
slowed skeletal development but did not provoke any patterning defects (Fig. 4.3D-E). 
These results suggested that LvLOX is functionally most similar to mammalian 5-LOX.  
We next tested the effects of adding LOX products 5(S)- and 12(S)-HETE to 
developing embryos. Since the 15-LOX inhibitor did not perturb development, we did not 
test 15(S)-HETE. Exposure to 5-LOX product 5(S)-HETE disrupted the growth and 
organization of the skeleton, while the 12-LOX product 12(S)-HETE had no observable 
effects on morphogenesis or skeletal patterning (Fig. 4.1, 4.3F). 5(S)-HETE treatment 
and LvLOX GOF provoked a similar profile of morphogenetic defects (Fig. 4.1B, 4.3B, 
F), suggesting that 5(S)-HETE is the molecular mediator for the LvLOX-mediated impact 
on skeletal patterning, consistent with the evidence above that LvLOX is a 5-
lipoxygenase. Interestingly, 12(S)-HETE exposure paralyzed swimming embryos (data 
not shown), suggesting a possible role in the regulation of ciliary beating or 
synchronization, while eliminating the potential contribution of a 12-LOX activity to 
skeletal patterning. These results indicate that LvLOX mediates its effects via 5(S)-HETE 




knockdown by the 5-LOX pathway inhibitor MK886. We therefore conclude that LvLOX 
is functionally most orthologous to mammalian 5-LOX.  
Skeletal patterning defects reflect perturbations to the ectoderm (Wolpert and 
Gustafson, 1961a; Hardin et al., 1992; Armstrong et al., 1993; Malinda and Ettensohn, 
1994; Hardin and Armstrong, 1997; Bradham and McClay, 2006; Duloquin et al., 2007; 
Adomako-Ankomah and Ettensohn, 2013a; Piacentino et al., 2015a; Piacentino et al., 
2016a; Piacentino et al., 2016b). To determine whether LOX influences skeletal 
patterning by regulating the establishment of embryonic axes within the ectoderm, we 
labeled serotonergic neurons, which arise within the anterior ectoderm, and ciliated cells, 
which form a narrow band at the DV ectodermal boundary in response to opposed, 
inhibitory dorsal and ventral TGFß signaling. When DV specification is inhibited, the 
ciliary band spreads broadly through the ectoderm (Duboc et al., 2004; Bradham and 
McClay, 2006; Yaguchi et al., 2006; Bradham et al., 2009; Yaguchi et al., 2010a). 
Neither loss- nor global gain-of-function perturbations to the LOX pathway impacted the 
spatial expression of these markers (Fig. 4.5), indicating both that LOX activity is not 
required for anterior-posterior or dorsal-ventral axial specification, and that the observed 
skeletal patterning defects are not downstream of major ectodermal reprogramming by 
LOX perturbation. Since VEGF, FGF, and Wnt5a are expressed in the ventrolateral 
ectoderm adjacent to PMC clusters and have been reported to be required for primary 
PMC patterning and general biomineralization (Duloquin et al., 2007; Rottinger et al., 
2008; Adomako-Ankomah and Ettensohn, 2013a; McIntyre et al., 2013b), we tested 




which is currently undefined) is impacted by LOX perturbation via qPCR analysis. The 
results show that none of them are significantly impacted by either MK886 or 5(S)-HETE 
treatment (Fig. 4.5F). These results indicate that LOX does not mediate its effects by 
perturbing the expression level of the known ventrolateral signaling ligands.  
4.4.2 LvLOX expression is spatiotemporally dynamic and its activity is required for 
bilateral orientation of the skeletal halves during a discrete temporal window 
To identify the temporal window during which skeletal patterning is sensitive to 
LvLOX inhibition, we first exposed embryos to MK886 for non-overlapping three-hour 
developmental windows and observed that, while the overall profile of skeletal patterning 
defects was relatively consistent across this time course (data not shown), embryos 
exposed to MK886 during later intervals exhibited an increase in the angle between left 
and right skeletal halves (Fig. 4.4A). This rotational defect about the anterior-posterior 
(AP) axis was most severe with treatment between 18 and 21 hours post fertilization (hpf) 
(Fig. 4.4A), indicating that AP skeletal orientation is regulated during this temporal 
window, which corresponds to primary PMC patterning (Piacentino et al., 2016b) (Fig. 
4.6). To more specifically define the temporal window of sensitivity to MK886, we next 
performed treatment time courses in which MK886 was introduced at each hour during 
development. We found that MK886 elicits skeletal patterning defects in at least 50% of 
embryos when introduced at any time before 24 hpf (Fig. 4.4B, red). Similarly, when 
MK886 was introduced at fertilization, then removed at hourly time points, we found that 
most embryos develop normally if MK886 is removed prior to 17 hpf but are sensitive to 




window of sensitivity to LOX inhibition between 17 and 24 hpf (Fig. 4.4B), which 
corresponds with the formation of the primary skeletal elements (Piacentino et al., 2016b) 
(Fig. 4.6).  
During this window of skeletal patterning sensitivity to LOX inhibition, LOX 
mRNA is expressed in distinct spatial regions within the ventral ectoderm. LOX is 
initially expressed in the apical ectoderm between 15 and 18 hpf, then additional 
expression domains arise in the posterior ventrolateral ectoderm between 18 and 21 hpf, 
then finally a third domain appears in the center of the posterior ventral ectoderm 
between 21 and 24 hpf, when the apical expression ceases (Fig. 4.4C). The posterior 
expression domains correspond spatially with the skeletal deficits observed upon LOX 
inhibition. First, the ventrolateral LOX expression domains are adjacent to the PMC 
clusters where the skeleton initiates as bilateral triradiates (Fig, 4.4C, schematics). Loss 
of ventrolateral LOX activity could account for the AP rotation defects observed with 
LOX MO and with MK886 treatment; these orientation defects likely result from 
abnormal triradiate orientation (Wolpert and Gustafson, 1961a), suggesting that 
ventrolaterally expressed LOX is required to normally orient the triradiates (Fig. 4.4A, 
Fig. 4.3A2, B). Second, the later posterior ventral ectodermal expression domain 
encompasses the ventral midline; this corresponds spatially with both the midline gaps 
and ventral rod defects frequently observed with LOX loss of function (LOF) (Fig. 4.1A, 
4.3A-B), suggesting that ventrally expressed LOX is required for ventral rod elongation. 
Interestingly, the defects observed with LOX gain of function (GOF) are in the dorsal 




(Fig. 4.4C), indicating that low and ectopic LOX activity provokes skeletal patterning 
defects in spatially distinct skeletal regions. Thus, aside from the apical domain, the 
expression pattern for LvLOX mRNA is spatiotemporally consistent with its observed 
functional role herein as an ectodermal skeletal patterning cue.  
The rotational defects observed with LvLOX inhibition are interesting, and likely 
result from orientation defects in the initial triradiate structures (Wolpert and Gustafson, 
1961a). The skeletal triradiates are planar, three-pronged biomineral structures that arise 
in the ventrolateral PMC clusters, and are the foundational structure of each skeletal half 
(Fig. 4.4C schematics, blue; Fig. 4.6D-F). To more precisely define the impact of LOX 
activity on skeletal orientation, we immunofluorescently labeled the skeletogenic 
mesoderm at pluteus stage in control and LOX-perturbed embryos, then mapped skeletal 
elements from confocal image stacks in three dimensions (3-D). Using this strategy, we 
collected coordinates for each component of the skeletal triradiates, calculated the plane 
in which each triradiate lies, then determined the angle between each triradiate plane and 
the plane bisecting left and right skeletal halves as a measure of the AP orientation of the 
triradiates (Fig. 4.4D1). We calculated the angles of left and right triradiates (Fig. 4.4D2-
3) as well as the orientation difference between the left and right sides in individual 
embryos (Fig. 4.4D4-5). In control embryos, both the angle between triradiates and the 
midline (rotation), and the similarity of angles made by the left and right triradiates 
within individuals (bilateral registry) were strikingly invariant, reflecting the predictable 
bilateral symmetry of the pluteus skeleton (Fig. 4.4D2, 4.4D4). Treatment with MK886 




increased angle between posterior skeletal halves observed in Fig. 4.4A and the AP 
rotation defects provoked by LOX LOF (Fig. 4.1A, 4.3A-B). MK886 also significantly 
decreased the bilateral registry within individuals (Fig. 4.4D4). Interestingly, global 
exposure to 5(S)-HETE also affected triradiate orientation, albeit less consistently, 
eliciting an increase in the rotation angle variability of the triradiates and a significant 
decrease in their bilateral registry (Fig. 4.4D2, 4, 5). The bilateral asymmetry of the 
triradiate planes observed within individuals agrees with the LR asymmetries observed in 
LOX GOF skeletons (Fig. 4.3B). These data suggest that bilateral organization of the 
skeleton is closely tied to orientation of the triradiates, and that LOX product 5(S)-HETE 
plays an active early role in orienting the skeletal halves, with respect to both the 
triradiate rotation angle and bilateral registry within individuals. Further, the overall 
skeletal growth and orientation defects observed following both 5(S)-HETE exposure and 
LvLOX mRNA injection (Fig. 4.3B, F) indicate that the normal coordination of 
bilaterally skeletal symmetry requires that LvLOX signaling activity is both present and 
spatially restricted during triradiate formation.   
4.4.3 Spatial organization of the PMC network is LvLOX-dependent 
Positioning of PMCs within the blastocoel defines the shape of the growing 
skeleton, and defects in PMC positioning lead to skeletal patterning defects (Wolpert and 
Gustafson, 1961b; Gustafson and Wolpert, 1967; Ettensohn and McClay, 1986; 
Armstrong et al., 1993; Hardin and Armstrong, 1997; Piacentino et al., 2015a; Piacentino 
et al., 2016a; Piacentino et al., 2016b). In Chapter Two, we devised an approach for 




PMC population into spatial domains in silico and determine the relative positional 
distribution of PMCs throughout skeletogenesis (Zuch and Bradham, 2019) (Fig. 4.6A). 
We used tbx2/3 expression to discriminate the dorsal PMCs (Croce et al., 2003a; Gross et 
al., 2003). We found that tbx2/3 is expressed in the dorsal part of the ring as expected, as 
well as in the cords, and is excluded from PMC clusters and the ventral part of the ring 
(Fig. 4.6A1-A2). In control embryos, we observed a stereotypical progression in which 
ingressed PMCs initially aggregate into two posterior bilateral clusters at 12 hpf, then 
migrate outward, populating two circumferential PMC chains that connect the bilateral 
clusters to form the posterior ring. This is followed by anterior migration of other PMCs 
from each cluster to form bilateral PMC chains, or “cords” (Fig. 4.6A-C). This initial 
progression, with clusters forming first, followed by ring formation, was unexpected, 
since it is generally accepted that the PMCs first form the posterior ring, then the bilateral 
clusters (Lyons et al., 2012). These results show that PMC migration patterns may be 
species-specific.  
 The "ring-and-cords" PMC pattern defines the primary skeletal pattern. 
Biomineral deposition begins in the bilateral PMC clusters within syncytial tubes that are 
positioned between the PMC cell bodies and the adjacent ectodermal substratum; the 
initial skeletal triradiates extend along the primary pattern (Fig. 4.6D). A subset of PMCs 
then migrates out of the ventrolateral clusters to secrete secondary skeletal structures, 
with posterior secondary migration of the ARs (aboral rods) occurring first (Fig. 4.6D). 
PMC labeling also allowed us to visualize skeletal rods at various timepoints and 




skeletal rods follows a highly predictable trajectory, in which triradiate elements (Anon 
(anonymous), DVC (DV connector), and VT) and the dorsal BRs (which branch from 
Anon) are well-formed by 22 hpf and comprise the primary skeleton (Fig. 4.6D-E; also 
see Fig. 4.3A-B).  Secondary elements begin to grow after 22 hpf, each branching from 
an endpoint of the triradiate elements. The posterior AR initiate first, followed by the 
anterior oral rods (OR) and finally the anterior recurrent rods (RR) (Fig. 4.6D-E; also see 
Fig. 4.3A-B). We further extrapolated from these data to model temporal skeletal growth 
in 3-D (Fig. 4.6F). 
Just prior to skeletogenesis, primary mesenchyme cells (PMCs) form a continuous 
network of syncytial tubes into which skeletal biomineral is deposited (Okazaki, 1965; 
Hodor and Ettensohn, 1998; Killian and Wilt, 2008; Ettensohn and Dey, 2017). 
Surprisingly, neither MK886 nor 5(S)-HETE treatment provoked overt disruptions to the 
primary PMC pattern (Fig. 4.7A). Given the primary skeletal defects provoked by either 
treatment, this finding was unexpected. However, both MK886- and 5(S)-HETE-treated 
embryos exhibited conspicuous disruptions in syncytial continuity, with evident gaps in 
the PMC ring and cords at each stage that was imaged. These gaps do not reflect 
significant changes in the number of PMCs that populate the ventral or dorsal PMC 
chains (Fig. 4.7A2). Gaps in the ventral portion of the ring predominated following 
LvLOX inhibition with MK886 (Fig. 4.7A3), while dorsal gaps were more pronounced in 
5(S)-HETE-treated embryos, particularly at earlier timepoints (Fig. 4.7A4). In pluteus 
stage embryos, MK treatment promoted significant truncations of the ventral midline 




the large syncytial gaps observed in the ventral PMC ring domain at earlier timepoints 
(Fig. 4.7A1, A3). Similarly, the dorsally biased skeletal truncations and gaps observed in 
5(S)-HETE-treated plutei correlate with the dorsal-biased gaps observed in the PMC ring 
at earlier timepoints (Fig. 4.7A4; see also Fig. 4.1 and 4.3). Together, these results show 
that LvLOX activity is required for PMC syncytial continuity, and, interestingly, 5(S)-
HETE is also sufficient to provoke syncytial discontinuity, particularly in the dorsal 
PMCs (Fig. 4.7A1, 3, 4).  
The syncytial gaps above prompted us to seek subtle defects in the primary spatial 
organization of the PMC population in LOX-perturbed embryos. We therefore extracted 
the 3-D coordinates for each PMC in late gastrula stage embryos (18 hpf) from confocal 
z-stacks, then measured the distances between neighboring PMCs (Fig. 4.7C1). We 
compared inter-PMC spacing within ventral and dorsal regions of the posterior PMC ring 
following vehicle, MK886, or 5(S)-HETE treatment (Fig. 4.7C). Measuring the inter-
PMC distances in the cords was challenging because the cords are dynamically extending 
at this stage and were more variable between individuals, unlike the consistent size of the 
PMC ring; accordingly, we limited this analysis to the PMC ring.  
In control embryos, PMC centers are typically separated by approximately 13 µm, 
compared to an average cell diameter of approximately 7 µm; thus, PMCs are normally 
spaced by 1.9 cell diameters. (Fig. 4.7C2). In embryos in which LOX was inhibited with 
MK886, the overall PMC spacing was significantly and variably increased in both ventral 
and dorsal domains to an approximate average of 16 µm or 2.3 cell diameters (Fig. 




along the posterior ring. In embryos globally exposed to 5(S)-HETE, the average inter-
PMC distance increased only in the dorsal ring domain, although not significantly (Fig. 
4.7C2). In both cases, these increases were largely due to the influence of a few very 
large outlier distances within each embryo, or ‘gaps.’ By comparing the largest inter-
PMC gap within each ring domain, we observed a significant increase in the prevalence 
of large gaps following both MK886 and 5(S)-HETE treatment (Fig. 4.7C3). MK886 
treatment provoked a large gap with an average of 34 µm or 4.9 cell diameters in both the 
ventral and dorsal ring domains, while 5(S)-HETE exposure provoked a large gap with an 
average of 38 µm or 5.4 cell diameters only within the dorsal ring domain (Fig. 4.7C3). 
When we subtracted the largest gap from each embryo and considered only the remaining 
inter-PMC distances, we found that 5(S)-HETE-treated embryos exhibit a significant 
decrease in PMC spacing, both dorsally and ventrally, to an average of 11 µm or 1.6 cell 
diameters (Fig. 4.7C4). Together, these results together show that LOX activity is 
necessary and sufficient to positively regulate cell spacing in the PMC ring.  
These findings imply a connection between the spatial distribution of PMCs and 
the formation of the syncytial connections between them, suggesting that the syncytial 
gaps observed with both treatments (Fig. 4.7A) result from aberrant and irregular PMC 
spacing. Syncytial gaps could arise simply from PMCs being locally too far apart, in the 
case of MK886 treatment, or alternatively from PMCs being generally too close together, 
creating gaps between tightly spaced PMC groups, in the case of 5(S)-HETE treatment. 
The dorsally enriched gaps in response to 5(S)-HETE (Fig. 4.7A3) are more difficult to 




4.7C4). The dorsal part of the PMC ring is 2x longer than the ventral part (Piacentino et 
al., 2016b; Zuch and Bradham, 2019) and therefore could be less flexible in 
accommodating tighter PMC spacing than the shorter ventral part of the PMC ring, 
potentially accounting for the dorsal enrichment of inter-PMC and early syncytial gaps 
with 5(S)-HETE treatment. Alternatively, gene expression differences in the ventral and 
dorsal PMCs (e.g. Fig. 4.6A) might account for this difference. The large gap sizes 
suggest that there is an inter-PMC distance limit of < 5 cell diameters for normal 
syncytium formation.  
We next assessed the spatiotemporal distribution of PMCs following LOX 
pathway perturbation by imaging PMCs at a range of timepoints. LOX inhibition delayed 
the secondary migration of PMCs from the ventrolateral clusters into the secondary 
elements (Fig. 4.8A1, 2). These results show that LOX activity is required for a normal 
rate of secondary PMC migration (Fig. 4.8A3), in agreement with the broad secondary 
skeletal patterning defects exhibited with LOX LOF (Fig. 4.3B). In contrast, 5(S)-HETE 
treatment had a minimal impact on PMC distribution and secondary migration rate from 
the PMC clusters (Fig. 4.8A1, 3).  
In some experiments, we transiently exposed embryos to the LOX inhibitor 
MK886 from 15 hpf, prior to the onset of skeletogenesis, through 24 hpf, when secondary 
skeletal patterning and growth is occurring. MK886 removal prompted the rapid 
resumption of PMC migration (Fig. 4.8B1), indicating that the effects of LOX signaling 
are acute and reversible. Surprisingly, the PMCs in these transiently inhibited pluteus 




4.8B1). These aberrant filopodial webs often coincided with and connected abnormally 
bent skeletal elements to other, normally positioned elements, notably to the aboral rod 
(AR) tip (Fig. 4.8B1, Fig. 4.9). This effect was only observed in embryos in which LOX 
was released from inhibition at 24 hpf but not with continuous LOX inhibition or with 
5(S)-HETE treatment (Fig. 4.8B2). These results suggest that LOX activity normally 
regulates filopodia to negatively impact their number, deployment, or connectivity in a 
spatially specific manner. From these examples (Fig. 4.8B, 4.9), LOX activity evidently 
prevents filopodia from connecting to the AR tip, which interestingly coincides spatially 
with the ventrolateral LOX expression domain. In addition, these abnormal connections 
reveal the normal spatial compartmentalization of the skeleton by providing examples of 
abnormal primary-to-secondary, anterior-to-posterior, and ventral-to-dorsal connections 
(Fig. 4.8B, 4.9A-C). These results suggest that LOX activity is required during primary 
patterning to define spatial PMC compartments and/or to suppress their interconnection. 
Because LOX inhibition slowed the outward migration of PMCs from the 
ventrolateral clusters (Fig. 4.8A), we reasoned that 5(S)-HETE may guide PMC 
positioning by acting as a chemoattractant, consistent with its role in immunological 
contexts (Powell and Rokach, 2005; Pidgeon et al., 2007; Powell and Rokach, 2015). We 
tested the effect of 5(S)-HETE on PMC migration in vitro using classical Boyden 
chambers (Fig. 4.8C1). For these experiments, we prepared PMCs by microinjection of in 
vitro transcribed SpPmar1 mRNA, which is sufficient to convert every blastomere to a 
PMC fate (Oliveri et al., 2003). For the in vitro migration assays, we employed horse 




found that 5(S)-HETE alone significantly provokes PMC migration to the same extent as 
horse serum, while the combination of horse serum and 5(S)-HETE provokes 
significantly more migration than either cue alone (Fig. 4.8C2), indicating that 5(S)-
HETE enhances serum-induced PMC migration. These results demonstrate that 5(S)-
HETE is sufficient to attract PMC migration in vitro and is thus pro-migratory cue for 
PMCs.   
4.4.4 Expression profiles of PMC-specific genes are LOX-dependent 
Gene expression within the PMC population becomes spatially heterogeneous 
following PMC ingression and migration (Croce et al., 2003a; Gross et al., 2003; Sun and 
Ettensohn, 2014; Piacentino et al., 2016b; Zuch and Bradham, 2019) (Fig. 4.6A), 
suggesting that specific PMC migratory and biomineralization behaviors depend on PMC 
diversification, which in turn depends on their differential receipt of positional cues in 
local sub-environments within the blastocoel. To determine whether LOX inhibition 
impacts PMC diversification, we isolated live PMCs from control and MK886-treated 
embryos via fluorescence-activated cell sorting (FACS), then subjected them to single-
cell RNA sequencing (Fig. 4.11A). We used well-known sets of markers for the various 
cell types within the embryo to assess the identity of the sorted PMCs and found that 82% 
of the sorted cells were indeed PMCs, while only 2.3% of the remainder cells were PMCs 
(Fig. 4.11B). After filtering out the non-PMCs, we combined the libraries for PMCs from 
MK-treated embryos to identify population-wide shifts in gene expression relative to 
PMCs from control and vehicle-treated embryos. Several genes that had been previously 




2012; Sun and Ettensohn, 2014) were significantly changed, including otop1, can1, sm34, 
msp130, jun, kirrelL, and pks2, in response to LOX inhibition (Fig. 4.11C). Of note, the 
transcription factor LvJun and the modular enzyme LvPks2 were significantly 
upregulated in individual cells, while biomineralization-related enzyme LvCan1 was 
moderately downregulated (Fig. 4.11C). In contrast, the expression of VEGFR and 
FGF20 was not significantly affected by MK886 treatment (Fig. 4.11C).  
4.4.5 Polyketide-synthase 2 (pks2) is LOX-pathway responsive, and is required for 
normal PMC patterning 
 To determine whether LOX impacts PMC diversification, we assessed the 
spatiotemporal expression of three known PMC subset genes that were identified as 
LOX-responsive from our single-cell sequencing analysis: LvJun, LvCan1, and LvPks2 
(Fig. 4.10, 4.12; see also Fig. 4.11). We employed fluorescence in situ hybridization 
(FISH) for these three genes combined with PMC labeling to map gene expression over 
the course of development with or without LOX pathway perturbation. Jun, a 
transcription factor with diverse cellular roles, and Can1, a carbonic anhydrase likely 
involved in biomineralization, have expression patterns that generally follow sites of 
active biomineralization, initiating in the ventrolateral clusters at late gastrula stage and 
expanding outward as PMCs undergo secondary migration and skeletogenesis, eventually 
accumulating in all PMCs that are not at distal-most rod tips (Fig. 4.12A-B). Following 
LOX inhibition, we found that the spatial expression profiles for jun and can1 were 
significantly delayed but otherwise normal compared to controls (Fig. 4.12A-B). 5(S)-




expression at 24 hpf, but otherwise did not perturb the expression of either gene (Fig. 
4.12B). Thus, for both jun and can1, LOX activity is required for the normal onset and/or 
spatial expansion of their expression, while LOX GOF has minimal effects. 
 In contrast, pks2 expression level and spatial pattern was significantly affected by 
LOX perturbation. In control embryos, pks2 expression is highly and uniformly 
expressed in PMCs as they ingress (Zuch and Bradham, 2019), then reduced to low levels 
in most cells, with isolated patches of higher expression in the clusters, cord tips, and at 
the midline by late gastrula stage (18 hpf), followed by a gradual reduction to a uniformly 
low level by early pluteus stage (36 hpf) (Fig. 4.10A, 4.12C). LOX inhibition with 
MK886 resulted in a dramatic increase in pks2 expression level and spatial domain (Fig. 
4.10A, 4.12C), with elevated levels and expanded ventral expression at 18 hpf followed 
by globally elevated expression at 24 hpf. At 30 hpf, pks2 is reduced in the ventrolateral 
clusters, and overall expression is further reduced at 36 hpf (Fig. 4.10A, 4.12C). These 
results indicate that LOX activity is required to negatively regulate pks2 expression, 
suppressing it in ventral PMCs at 18 hpf, when LOX is expressed in the ventrolateral 
ectoderm, then globally at 24 hpf, when LOX is expressed ventrally and ventrolaterally. 
At 30 hpf in MK886-treated embryos, pks2 is repressed in a LOX-independent manner in 
the proximal skeleton, and that effect spreads distally at 36 hpf (Fig. 4.10A, 4.12C). 5(S)-
HETE exposure provoked ventral activation of pks2 expression at 18 hpf that is very 
similar to the effect of MK886. Subsequently, 5(S)-HETE-treated embryos on average 
display pks2 expression that is moderately elevated but otherwise similar to controls (Fig. 




generally activate pks2 at later time points, when 5(S)-HETE is not sufficient to spatially 
perturb pks2 expression. Since 5(S)-HETE did not simply inhibit pks2 expression, 
producing a reciprocal effect compared to MK886, the regulatory relationship between 
LOX activity and pks2 expression is more complex than simple negative regulation.  
 At later time points, both treatments induced local patches of highly elevated pks2 
expression within the PMC network in locations that varied from embryo to embryo (Fig. 
4.10B1). Interestingly, in 5(S)-HETE-treated embryos, PMCs in the ventrolateral clusters 
with highly elevated pks2 expression also consistently failed to migrate from the 
ventrolateral clusters (Fig. 4.10B1, asterisks). While pks2 levels were generally elevated 
by LOX perturbation (Fig. 4.10B2), pks2 expression was starkly elevated within 
migration-defective PMCs in 5(S)-HETE-treated embryos (Fig. 4.10B3). This 
observation agrees with the approximately 30% of 5(S)-HETE-treated plutei that exhibit 
severe unilateral PMC migration and skeletal patterning defects, in which one half of the 
skeleton fails to form (e.g., Fig. 4.10B1, asterisk) or is severely stunted, as reflected 
quantitatively by the high incidence of LR asymmetries observed with LOX GOF (Fig. 
4.3B). These findings imply that excessively high levels of pks2 expression inhibit PMC 
migration. This contention is supported by the correlation of diminished expression of 
pks2 in the PMC clusters with their subsequent migration in MK886-treated embryos at 
30 and 36 hpf, respectively (Fig. 4.10A).  
 In LOX-perturbed embryos, we also sometimes observed pks2 mRNA 
accumulation in the syncytial cables that connect groups of PMCs that highly express 




expression (Fig. 4.10B4). This apparent diffusion boundary in the cable could reflect a 
syncytial discontinuity in response to LOX perturbation. However, a similar effect was 
consistently observed with tbx2/3 mRNA in control embryos: tbx2/3 accumulates in the 
syncytial cables specifically at the boundary between the PMC cluster and the dorsal half 
of the PMC ring, which corresponds to the tbx2/3 spatial expression boundary (Fig. 
4.10B4), implying that tbx2/3 movement is gated at this location. In contrast, GFP protein 
is capable of moving throughout the PMC syncytium (Bradham et al., 2004; Schatzberg 
et al., 2015), indicating that such gating is not general. Together, these findings suggest 
that syncytial barriers exist in control embryos that selectively, abruptly regulate the 
movement of specific mRNAs. Such selective syncytial gates are a potential means of 
controlling gene expression territories within PMC spatial subdomains, as observed 
herein for tbx2/3 (Fig. 4.10B3, 4.6A).   
 We assessed the functional role of LvPks2 by blocking its expression with a 
zygotically-injected translation-blocking morpholino. We found that pks2 morphants 
develop normally through gastrulation, then, interestingly, cease to develop further (Fig. 
4.10C1). This presented an unfortunate obstacle to assessing the requirement of Pks2 for 
skeletal patterning. We were, however, able to inspect the state of the PMC population at 
late gastrula stage, and we observed a disordered PMC network, with disconnected PMCs 
in the anterior cords, and a distinct lack of PMCs populating the ventral portion of the 
ring (Fig. 4.10C2-3). Together, these results indicate that Pks2 is required for primary 






In this study, we demonstrate that LvLOX, functionally defined as a 5-
lipoxygenase, is a sea urchin skeletal patterning cue. We show that spatially restricted 
LvLOX activity is required to regulate the orientation and bilateral registry of the initial 
skeletal triradiates, and for the normal formation of ventral skeletal elements (Fig. 4.1, 
4.4). We observed discontinuities in the PMC syncytial network following both 5-LOX 
inhibition and global exposure to 5-LOX product 5(S)-HETE; at the pluteus stage, these 
syncytial gaps correlate spatially with the skeletal defects in LOX-perturbed larvae (Fig. 
1, 4.7A). Further, we found that LOX is necessary and sufficient to regulate the spacing 
between neighboring cells in the PMC ring (Fig. 4.7C). In vivo, LOX activity is required 
for the secondary migration of PMCs from the PMC clusters, while in vitro, 5(S)-HETE 
is sufficient to attract the migration of PMCs (Fig. 4.8). Transient LOX inhibition 
induced the formation of aberrant filopodial webs that connect the long posterior 
secondary rods (ARs) to PMCs associated with skeletal elements in other spatial domains 
that are consistently malformed and/or ectopically positioned (Fig. 4.8 and 4.9). 
Together, these results indicate that LvLOX activity regulates PMC migration, local 
positioning, and physical connectivity. We identified and spatially mapped the expression 
of several LOX-dependent PMC subset-specific genes (Fig. 4.10, 4.11, and 4.12). 
Polyketide synthase-2 (pks2) expression in particular is dramatically increased by both 
MK886 and 5(S)-HETE treatment; highly elevated pks2 expression often correlates with 
severe PMC migration defects (Fig. 4.10 and 4.12), while knockdown of pks2 indicates 




Together, these data support a model for LOX function during skeletal patterning (Fig. 
4.13). 
LOX expression is spatially dynamic, with early apical expression, shifting to 
apical and ventrolateral expression between 18 and 21 hpf, then adding a ventral 
expression domain between 21 and 24 hpf. The apical region is neurogenic, and whether 
LOX plays an early role in that location remains unclear, since LOX inhibition has no 
obvious impact on the specification of apical serotonergic neurons; moreover, inhibition 
of LOX prior to 18 hpf has little phenotypic effect; rather, we find that the functional 
requirement for LOX activity occurs between 17 and 24 hpf, corresponding with both the 
posterior expression of LvLOX and the onset of skeletogenesis.  
Ventrolateral LvLOX expression in the ectoderm from 18-21 hpf coincides with 
the formation of the initial triradiates in the adjacent PMC clusters. We observe three key 
defects during this interval in LOX-perturbed embryos. First, the AP orientation of the 
triradiates is sensitive to LOX perturbation particularly during the interval from 18-21 
hpf, indicating that ventrolaterally expressed LOX regulates the triradiate angle (Fig. 
4.13A1). Interestingly, bilateral symmetry is decoupled with both LOX inhibition and 
with 5(S)-HETE treatment, with 5(S)-HETE having the stronger effect. The mechanisms 
underlying the control of bilateral symmetry are unclear, and it is possible that this 
control reflects a global coordinate system of some kind that the cluster PMCs detect and 
use to align the triradiates; alternatively, bilateral symmetry could occur instead via local 
control, in which each skeletal triradiate is independently oriented. In either case, since 




GOF, this suggests that triradiate orientation and bilateral registry are regulated by a 5(S)-
HETE-dependent scaffold that tethers together two necessary factors (Fig. 4.13A2, blue). 
In this model, if 5(S)-HETE levels are abnormally low, the scaffold is not expressed and 
the factors are not tethered together, whereas with excessive 5(S)-HETE, the scaffold is 
overexpressed and independently binds the factors, which again are not tethered together 
efficiently. In the model, this putative scaffold is induced only at the highest 
concentrations of 5(S)-HETE in the ventrolateral regions of the embryo, where LOX is 
expressed and where the triradiates form (Fig. 4.13A2). While other interpretations could 
also explain these results, a scaffold-based mechanism is likely the simplest model.  
The second defect is in the local organization of the PMCs, such that LOX 
activity is necessary and sufficient to positively regulate PMC spacing within the chains 
of PMCs that form the ring and cords (Fig. 4.13A1). The formation of inter-PMC gaps 
and syncytial breaks occurs with both LOX LOF and GOF; however, these large-scale 
effects are probably due to the perturbation of inter-PMC spacing, since inappropriate 
PMC positioning, whether abnormally close or far apart, will cause the population to 
form gaps. In this model, inter-PMC spacing is the initial defect, and since LOX LOF and 
GOF provoke reciprocal effects, this suggests that inter-PMC spacing is regulated by 
LOX via a distinct, scaffold-independent mechanism. PMC spacing is unlikely to be 
acutely regulated by the ectoderm since PMCs are not statically positioned at precise 
locations; moreover, low numbers of PMCs suffice to generate normal skeletons 
(Ettensohn, 1990; Zuch and Bradham, 2019). The highly uniform distribution of PMCs in 




interactions between PMCs locally stabilizes their relative positions. Our results suggest 
that LOX activity promotes attractive interactions between PMCs, such that when LOX is 
inhibited, the repulsive effects are imbalanced, and vice versa (Fig. 4.13A1).  
The third defect is in the regulation of pks2 expression, which is dramatically 
activated and spatially disrupted by LOX perturbation at 18 hpf. At late gastrula stage, 
the expression of pks2 is restricted to PMCs in the ventral midline in Strongylocentrotus 
purpuratus (Sun and Ettensohn, 2014). However, at the comparable stage in Lytechinus 
variegatus, pks2 is expressed in a more complex pattern within the PMCs, with discrete 
expression domains in the clusters, the ventral and dorsal midline, and the cord tips (Fig. 
4.10A, 18 hpf). Since pks2 expression initiates early in all PMCs (Rafiq et al., 2012; Zuch 
and Bradham, 2019), it is likely activated without spatial specificity by a pan-PMC 
activator such as ets or alx1. Our results show that LOX mediates pks2 spatial repression. 
The pks2 expression pattern at 18 hpf is similarly dysregulated following both MK886 
and 5(S)-HETE treatments (Fig. 4.13A3), again implying that LOX mediates pks2 
repression via a 5(S)-HETE-dependent scaffold that tethers together two necessary 
factors. A scaffold that is optimized by a medium dose of 5(S)-HETE can account for the 
expression pattern of pks2 (Fig. 4.13A2, brown). In this model, pks2 is repressed only 
where 5(S)-HETE levels are moderate, but repression fails to occur when 5(S)-HETE 
levels are high (laterally) or low (at the midline and cord tips) (Fig. 4.13A2-3). Thus, it 
appears that three different mechanisms are employed downstream from 5(S)-HETE at 
18 hpf: scaffold-dependent regulation of triradiate orientation at high 5(S)-HETE levels, a 




scaffold mechanism that regulates inter-PMC spacing. Since 5(S)-HETE is known to 
impinge on multiple signaling pathways in the mammalian immune system (Powell and 
Rokach, 2015), it seems unsurprising that LOX activity also appears to modulate a 
variety of pathways via multiple mechanisms in this context.  
Between 21 and 24 hpf, LOX becomes expressed within the ventral ectoderm, 
adjacent to the ventral portion of the already-established PMC ring, which produces the 
ventral transverse (VT) skeletal elements during this interval (Fig. 4.13B1). The VTs 
require LOX activity for their final extension, termination, and fusion, implicating local 
LOX activity as specifically, positively directing medial biomineral growth within the 
ventral PMC chain (Fig. 4.13B1).  
We found that LOX perturbation does not impact the overall primary PMC 
pattern, yet does affect the primary skeletal elements. LOX activity positively regulates 
inter-PMC spacing in PMC chains, and LOX perturbation results in syncytial gaps and 
skeletal patterning defects that spatially correlate; we thus hypothesize first, that the LOX 
perturbation-mediated changes in PMC spacing, both negative and positive, lead to larger 
inter-PMC gaps that prevent a syncytial connection, such that syncytium formation is 
dependent on a critical inter-PMC distance of < 5 cell diameters, and second, that 
skeleton formation is subsequently dependent on syncytium formation. 
The truncations of dorsal elements that we observe when LvLOX is ectopically 
expressed or embryos are exposed to 5(S)-HETE imply that the ventral and dorsal PMCs 
exhibit differential sensitivity to LOX activity with respect to both the formation of 




require LOX signaling for their synthesis but the dorsal elements do not tolerate LOX 
signaling at high levels. This DV difference may be accounted for by the expression of 
tbx2/3 and/or other genes in dorsal but not ventral PMCs (Croce et al., 2003a; Gross et 
al., 2003; Sun and Ettensohn, 2014; Zuch and Bradham, 2019) (Fig. 4.6), such that the 
specific gene regulatory network (GRN) that is operant in dorsal PMCs executes an 
abnormal biomineralization response to ectopic and precocious 5(S)-HETE exposure that 
is distinct from the normal ventral PMC GRN response to 5(S)-HETE, which begins at 
21 hpf when the ventral expression of LOX initiates.  
At 24 hpf, lvpks2 expression is ventrally diminished and dorsally enhanced 
compared to 18 hpf in control embryos. Pks2 repression fails when LOX is inhibited, and 
pks2 is globally highly expressed (Fig. 4.13B3), whereas 5(S)-HETE treatment results in 
generally elevated pks2 expression that is otherwise comparable to the control expression 
pattern, indicating a milder loss of the normal repressive effect (Fig. 4.13B3). In our 
model, the change in LOX spatial expression provokes a change in the spatial gradient of 
5(S)-HETE and thereby, a change in the spatial expression of the pks2 repressive scaffold 
(Fig. 4.13B2), accounting for these effects.  
The expression pattern of pks2 at 18 hpf is quite interesting, since it marks regions 
in the primary PMC pattern that coincide with future skeletal branch points (Fig. 4.13C1-
2, asterisks) or rod terminations (Fig. 4.13C1-2, double asterisks) as previously suggested 
(Sun and Ettensohn, 2014), potentially defining these future sites while the skeleton is 
only at the triradiate stage. At 24 hpf, pks2 expression declines in the PMC clusters, 




HETE treated embryos (Fig. 4.13C3); however, when LOX is inhibited, secondary PMC 
migration from the ventrolateral clusters is blocked, and this correlates with abnormally 
high expression of pks2 in the ventrolateral PMCs (Fig. 4.13C4). In LOX-inhibited 
embryos, pks2 expression levels decline in the PMC clusters at 30 hpf (Fig. 4.13C5) and 
secondary migration initiates at 36 hpf (Fig. 4.13C6), consistent with a model in which 
the repression of pks2 in the clusters is required for their secondary migration (Fig. 
4.13C4-6). The substantially delayed secondary migration in LOX-inhibited embryos 
likely explains their secondary skeletal patterning defects. Since the functional 
requirement for LOX activity significantly diminishes after 24 hpf, it seems likely that 
the later regulation of pks2 reflects the activity of other LOX-independent factors that 
impinge on pks2.  
We previously found that the gene product of SLC26a2/7 (SLC) is required for 
formation of the VTs (Piacentino et al., 2016b). SLC functions earlier than LOX, with a 
temporal window of action ending at 16-18 hpf, and  is required for PMCs to migrate to 
the ventral domain during this relatively early window of activity (Piacentino et al., 
2016b) (Fig. 4.13D). We observed a similar result with LvPks2 knockdown, 
demonstrating that pks2 is specifically required for ventral PMC migration. Pks2 
morphants also entirely lack biomineral, and we therefore hypothesize that the early, pan-
PMC expression of pks2 is required to induce their competence for biomineral formation. 
LOX expression arises ventrally between 21 and 24 hpf, which corresponds with the 
extension of the VTs. In our model, ventral LOX activity is required for VT elongation 




(Fig. 4.13C1, E). Thus, the model suggests that mechanism underlying the formation of 
the VTs depends first on SLC function in the ventral ectoderm, along with pks2 
expression in the PMCs, to attract ventral PMC migration (Fig. 4.13D), then on later 
LOX activity in the ventral ectoderm, which promotes the final extension of the VT 
biomineral to the ventral midline, and finally on pks2 expression, possibly earlier, in the 
ventral midline PMCs to signal or otherwise confer biomineral termination (Fig. 4.13E). 
Pks2 is a modular enzyme (Staunton and Weissman, 2001; Castoe et al., 2007) with an 
unknown function; such enzymes often produce exotic molecules such as tetracycline 
(Staunton and Weissman, 2001), and it will be thus of interest to identify the product of 
Pks2 activity and determine whether it suffices to branch or terminate skeletal rods as 
predicted by our model. Together these findings highlight a novel role for the 5-LOX 










Figure 4.1 Lv5-Lipoxygenase is required for skeletal patterning. A. LOX is required 
for normal skeletal patterning. A1. Representative morphologies (DIC, top) and 
associated skeletal birefringence (plane-polarized light, middle) are shown for indicated 
treatments; schematics (bottom) illustrate corresponding skeletal elements and 
organization. A2-3. The fraction of embryos with defective ventral-transverse rods (VTs) 
(A2) or midline gaps (A3) is shown for indicated treatments. B. LOX gain of function 
perturbs skeletal patterning. B1. Representative morphologies (DIC, top) and associated 
skeletal birefringence (plane-polarized light, middle) are shown for indicated treatments; 
schematics (bottom) illustrate corresponding skeletal elements and organization. B2. The 
fraction of embryos with defective body rods (BRs) is shown for indicated treatments. n 







Figure 4.2 Lvlox is expressed throughout development, with elevated expression 
during skeletogenesis. Temporal expression of LvLOX mRNA is displayed as 
normalized RNA-Seq counts over 11 developmental timepoints ranging from zygote (0 
hpf) to pluteus (48 hpf) (from Hogan et al, 2020). The normal progression of sea urchin 










Figure 4.3 Perturbation of the 5-LOX pathway elicits a spectrum of skeletal 
patterning defects. A. Schematics (top panel) and skeletal exemplars (lower panel) are 
shown to depict normal pluteus-stage skeletal elements from anterior (left) and lateral 
(right) views (A1) and abnormal orientation defect classification in terms of body axes 
(“AP”, “DV”, “LR”), using MK886-treated embryos as exemplars (A2) B. Quantitation 
of all skeletal growth and orientation defects for LOX-perturbed embryos is depicted as 
the fraction of embryos that exhibit the indicated defects; n ³ 67 for each condition. C. A 
schematic representing the lipoxygenase pathway is shown that depicts pharmacological 
inhibitors (red) that target the activity of each of the specific LOX enzymes (blue). 
Abbreviations are AA, arachidonic acid; COX, cyclo-oxygenase; FLAP, 5-
Liopoxygenase activating protein; GPCR, G protein-coupled receptor; PC, 
phosphatidylcholine; PG, prostaglandin; PI3K phosphatidyl inositol 3-kinase; PKC, 
protein kinase C; and PLA2, phospholipase 2. D. Representative skeletons and associated 
DIC images (insets) are shown for embryos injected with LOX MO or treated with the 
LOX-targeting drugs as indicated. E. Pluteus skeletons were scored for individual 
primary skeletal element losses and orientation defects, displayed as a fraction of total 
observed embryos for the indicated treatments; n ³ 34 for all conditions. F. LOX gain of 
function perturbs the dorsal skeleton. Representative skeletons and associated DIC 
images (insets) for embryos injected with LOX mRNA or treated with LOX-pathway 
metabolites as indicated (F1). The fraction of embryos with defective skeletons was 








Figure 4.4 LvLOX expression is spatially dynamic and regulates bilateral skeletal 
orientation within a discrete temporal window. A. The angle between posterior 
skeletal rods was measured from polarized light images of embryos treated with MK886 
for the indicated 3-hour developmental windows; n³10 for all conditions. B. The 
frequency of defective skeletons is shown when treated with MK866 from the indicated 
time-points through pluteus stage (red bars, “MK addition”), or when treated with 
MK886 from zygote through the indicated time-points (blue bars, “MK removal”), then 
allowed to develop to pluteus stage. At least 50% (red line) of observed embryos were 
defective for both treatment regimens between 17 and 24 hpf (dashed lines, “MK 
perturbation window”); n ³ 31 for each condition. C. LOX expression is spatially 
dynamic. Spatial expression of lvlox (red, lox) is shown at indicated time points alone 
(top panel) or overlaid with DIC and the ventral marker chordin (green, chd) (middle 
panel). The bottom panel shows a schematic of the observed lvlox spatial expression 
pattern (red) and skeletal development (blue) at each time point. D. LOX perturbation 
results in aberrant triradiate orientation. D1. Pluteus stage embryos were immunolabeled 
for primary mesenchyme cells and imaged in 3-D using 2.5 µm confocal z-steps. 
Endpoints (arrowheads) of elements comprising the skeletal triradiates were collected and 
used to calculate the plane passing through each triradiate in 3D space. D2, the angles 
between each triradiate plane and the left-right bisecting plane in pluteus-stage embryos 
were plotted for the indicated treatments as individual values and the mean ± s.e.m. D3. 
Schematic illustrating mean angles from panel D2 for control (gray, left) and MK (red, 




bilateral midline plane. D4. The difference between angles for opposite triradiates within 
individual embryos is shown as the mean + s.e.m.; D5. Schematic illustrating the mean 
individual angle differences in panel D4 for control (gray, left) and 5-HETE (blue, right) 
treatments. Scale bars indicate 20 microns; * p < 0.05, ** p < 0.005, *** p < 0.0005 





Figure 4.5 LOX pathway perturbation does not impact the establishment of 
anterior-posterior or dorsal-ventral embryonic axes, or perturb ectodermal 
ventrolateral signal expression. A. A schematic representing the location of 
serotonergic neuron (ser, green) formation in the anterior oral hood is shown as a readout 




confocal phase images are overlaid with z-projections of immunofluorescently labeled 
serotonin for the indicated treatments. C. A schematic representing the location of the 
ciliary band (red) formation at the boundary between ventral and dorsal signaling 
domains is shown as a readout for the positioning and establishment of the dorsal-ventral 
axis. D.-E. Representative confocal z-projections of ciliary band immunofluorescent 
labeling are shown in late plutei for the given treatments (D) with corresponding single-
plane phase images (E). MK886- and 5(S)-HETE-treated embryos are shown in an 
anterior, top-down view. F. qPCR showing the effects of MK886 and 5(S)-HETE on 
ectodermal genes. Dashed lines indicate a significance threshold at ∆CT of ±1.7 








Figure	4.6	Modeling PMC position and skeletal growth dynamics in 3-D. A. Time 
course analysis shows that PMCs migrate from initial ventrolateral clusters into the 
posterior ring, then finally extend cords anteriorly. A1. Control embryos are shown at the 
indicated timepoints after both PMC labeling (green) and dorsal marker tbx2/3 labeling 
(red). Representative confocal phase images are overlaid with z-projections of 
immunolabeled PMCs (top), corresponding fluorescence in situ hybridization (FISH) 
signal for dorsal marker tbx2/3 (middle), and with both PMCs and tbx2/3 signals overlaid 
(bottom) at indicated developmental timepoints. A2-3. Models are shown that depict 
mapped 3-D locations for individual PMCs in embryos displayed in panel A1, along with 
either the binary tbx2/3 expression scores for each PMC (A2, red) or with the locations 
and assigned spatial domains for each PMC (A3, colors per B and C). B.-C. The number 
of PMCs in the clusters steadily diminishes as primary patterning occurs. The proportion 
of PMCs assigned to each spatial domain is shown as the mean ± s.e.m (dashed lines) (B) 
and the fraction (C) at indicated time points; n ³ 5 embryos for each condition. D.-F. 
Secondary posterior skeletal growth dynamics are mainly smoothly increasing, although 
the posterior secondary aboral rods (ARs) undergo abrupt elongation at late time points. 
D. Representative confocal z-projections of immunolabeled PMCs are shown at the 
indicated timepoints (upper panel); skeletal elements (white) are overlaid on the same 
PMC z-projections (lower panel). E. 3-D measurements of individual skeletal rod lengths 
are plotted at the indicated developmental timepoints. See Fig. 4.3 B1 for skeletal rod 
key. F. Three-dimensional models of skeletal growth generated from mean rod lengths in 





Figure 4.7 Spatial organization of the primary mesenchyme cell network is 
regulated by LOX pathway signaling. Embryos were treated with MK886 or 5(S)-
HETE, then fixed at a range of developmental timepoints and labeled for PMCs. A. 
PMCs exhibit syncytial discontinuities in LOX-perturbed embryos. A1. Representative 
confocal z-projections of immunolabeled PMCs, and associated schematics showing gaps 




relative PMC distribution is normal in the ventral and dorsal regions at 18 hpf; n = 10 for 
each condition. A3-4. Gaps in the syncytial network were counted within the ventral (A3) 
and dorsal PMC chains (A4) between 18 and 42 hpf. Graphs show mean ± s.e.m. (dashed 
lines) at indicated time points; n = 10 for each condition. B. LOX inhibition induces 
midline gaps in the ventral transverse rods. B1. Representative confocal z-projections of 
ventral transverse skeletal elements (VTs) in pluteus stage control (upper panel) and 
MK886-treated embryos (lower panel). B2-3. VT length (B2) and ventral gap length (B3) 
were calculated by Euclidean distance between 3-D skeletal rod endpoint coordinates. 
The results are presented as mean + s.e.m. C. Lox is required to fine-tune PMC spacing. 
C1. For PMCs in the dorsal and ventral domains of the posterior ring, the distance was 
measured between each PMC and it’s two nearest neighbors in 3-D space. C2-3. The 
Euclidean distance between PMC centers is plotted for the indicated treatments (C2). The 
largest inter-PMC distance is shown as individual distances (C3), and the distance 
between PMC centers excluding the largest inter-PMC distance in each embryo is also 
shown (C4); in each plot, the data are presented as individuals as well as the mean ± 
s.e.m.; * p < 0.05, ** p < 0.005, *** p < 0.0005; n = 10 for all conditions. Scale bars 








Figure 4.8 LOX is required for normal PMC migration and filopodial restriction. A. 
Secondary PMC migration is delayed in LOX-inhibited embryos. A1. Embryos were 
treated with MK886 or 5(S)-HETE, then fixed at multiple developmental timepoints and 
labeled for PMCs. Representative confocal z-projections show PMC configurations at 
indicated timepoints; the ventrolateral region is indicated by arrowheads. A2. The 
schematic shows PMCs in the ventrolateral cluster (dark gray) at late gastrula that 
subsequently migrate to form secondary anterior and posterior structures in plutei (light 
gray). Note that the cluster PMCs that migrate anteriorly are thought to displace the 
PMCs that originally occupied those skeletal elements, as indicated. A3. The proportion 
of PMCs remaining in the ventrolateral PMC clusters was quantitated for indicated 
treatments between 18 and 42 hpf and is shown as the mean ± s.e.m (dashed lines and 
gray shading) at indicated time points; n = 10 for each condition. B. Transient LOX 
inhibition provokes filopodial abnormalities. B1. Embryos were treated with MK886 for 
a nine-hour window spanning the initiation of primary and secondary skeletogenesis (15-
24 hpf), then fixed and stained for PMCs at the pluteus stage (42 hpf). Representative 
confocal z-projections (left) and magnified insets (right) are shown for the indicated 
treatments. The arrow indicates the AR rod tip, while arrowheads indicate inter-domain 
filopodia. B2. Abnormal filopodial connections extending between skeletal elements 
were quantified, and are shown as mean ± s.e.m.; n ³10 for each condition (B2). C. 5(S)-
HETE is an attractive migratory cue in in vitro. C1. PMC migration was measured in 




migration index is shown as mean + s.e.m; n = 3 for each condition. * p < 0.05; ** p < 






Figure 4.9 Release of LOX inhibition results in ectopic inter-PMC filopodial 
connections and corresponding ectopic skeletal growth. A. Representative confocal z-
projections of PMCs in pluteus stage larvae that were treated with MK886 for a 9-hour 
window between 15 and 24 hpf, which exhibit abnormal filopodial connections (white 
arrowheads) between specific skeletal domains. Domain-spanning filopodia occasionally 
contained PMCs (yellow arrow). The regions outlined with dotted boxes in the upper 




orientations and ectopic inter-PMC filopodia that abnormally spanning specific PMC 
domains is shown for the indicated abnormalities. C. Schematics illustrating the normal 
directional extension of skeletal elements (black lines) compared to the aberrant growth 
(red lines) and associated filopodial connections (red hatch). D. Representative skeletal 
images are shown alone (top panels) or overlaid with DIC images (bottom panels) as 
exemplars of the observed aberrant skeletal growth paradigms illustrated in panel C. Note 
the ectopic OR that fails to occupy the oral hood. E. The frequency of specific skeletal 
defects resulting from temporary LOX inhibition during primary skeletal element growth 






Figure	4.10	Figure 6. Polyketide synthase-2 (pks2) expression is regulated by LOX 
activity and is required for normal PMC spatial organization. A.-B. LOX activity 




5(S)-HETE (HETE), fixed at multiple developmental timepoints, then subjected to 
fluorescence in situ hybridization for pks2 and subsequently immunolabeled for PMCs. 
A2. The expression level of pks2 was spatially mapped, then averaged across defined 
spatial subdomains within the PMC population, ranging from 15 domains at the earliest 
timepoints to 23 domains at the latest timepoints (Fig. 4.12C). The expression score 
represents the average pks2 expression level within discrete PMC zones; the results are 
shown schematically; n = 10 embryos per condition (A2). B. Pks2 is sometimes 
expressed at highly elevated levels in discrete patches of PMCs in LOX-perturbed 
embryos. B1. Exemplars are shown of MK- and HETE-treated embryos with patches of 
highly elevated pks2 (arrowheads); in 5(S)-HETE, such patches exhibit stalled migration 
(asterisks; compare with opposite side that exhibits normal migration (arrow). B2. 
Individual PMCs expressing elevated pks2 were counted per embryo for indicated 
treatments at the given timepoints. Individual counts were plotted with the mean ± s.e.m.; 
n = 10 for each condition. B3. Individual PMCs expressing pks2 at abnormally elevated 
levels within ventrolateral cluster domains in pluteus stage embryos were counted and 
categorized based on whether the cluster was migration competent or incompetent; 
results are shown as individual counts with mean ± s.e.m.; n = 10 for each condition. B4. 
Pks2 mRNA (upper panel) and tbx2/3 mRNA (lower panel) accumulate in the PMC 
syncytium connecting PMC chains (small arrowheads), with dramatic spatial limits (large 
arrowheads).  C. Pks2 is required for biomineralization and for ventral PMC migration. 
C1-2. Embryos zygotically injected with control MO or LvPks2 MO (0.4 mM) are shown 




nuclei (dapi, blue) as indicated (C2); arrowheads indicate the ventral region of the 
posterior PMC ring. C3. The spatial distribution of PMCs in control and pks2 MO-
injected embryos is shown as the average percentage of PMCs within each indicated 
domain ± s.e.m.; * p < 0.05, ** p < 0.005, *** p < 0.0005 compared with control; n = 8 






Figure 4.11 Expression profiles of PMC-specific genes are subject to LOX-
dependent regulation. A. A schematic shows the single-cell PMC sequencing approach. 
B. Cell type assignments from FACS sort of PMCs (left) and remainder populations 
(right). C. A volcano plot shows gene expression changes in PMC populations isolated 




control PMCs. Single cell expression profiles were combined to identify population-wide 
expression shifts in PMCs from MK886-treated embryos relative to PMCs from untreated 







Figure 4.12 Spatial-distribution of PMC-specific genes is regulated by LOX activity. 
A.-C. LOX perturbation modulates PMC subset-specific gene expression. PMCs (red)  




treatments, for genes jun (A1) and can1 (B1). The spatial expression dynamics for these 










Table 4.1 qPCR primer sequences 
 
Primer Sequence (5’ --> 3’) 
LvSetmar forward GCCATCATGTCCTTGTCTCA  
LvSetmar reverse  CACATGAAGCTTGATCAGGTAGTC  
LvWnt5a forward CGAGCTCTTCATCCTTGGTACA  
LvWnt5a reverse TGGTCCTGGTAGAGCTGACATA  
LvVEGF forward CTACAAAGGAAGGCGGAACG  
LvVEGF reverse GCTCCGTTGATACATGGTGG  
LvVEGFR forward CCACCATCACCCATCAAACCACC  
LvVEGFR reverse CCCTGACCTGAATCCACTGG  
LvFGF forward GGTTGCATAGCTGGAGCCCAATGA 
LvFGF reverse CCTTTTGTTGGTGCTGTCTGGCATC 
LvFGFR forward TTCAACAGGAACGCTAGGGT 






Table 4.2 Marker genes for single-cell transcriptome filtering 
 
Population marker Gene SPU # 
Ventral Ectoderm LvChordin SPU_004983 
LvNodal SPU_011064 
LvNot1 SPU_002129 
Dorsal Ectoderm LvIrxA SPU_012772 
LvMsx SPU_026277 
Endoderm LvEndo16 SPU_011038 
LvHox11/13b SPU_002631 
Neural LvSix1/2 SPU_017379 
LvSix3 SPU_018908 














5.1 Summary of Findings 
 
The sea urchin embryo is a valuable and tractable model for assessing 
morphogenetic regulation during embryogenesis. A number of recent studies have 
identified factors that participate in the regulation of primary mesenchyme cell (PMC) 
migration and biomineralization, laying the foundation for a comprehensive model of 
skeletal morphogenesis. Most of the factors identified thus far are required for broad 
regulatory control of these biological processes, painting an incomplete picture that 
doesn’t account for local morphogenetic events. In this dissertation we discover and 
determine the functional requirements for two ectodermal factors that operate locally to 
modify PMC behavior and pattern specific, localized aspects of skeleton formation. 
Notably, we present SLC26a2/7 and 5-lipoxygenase as regulators of skeletal patterning, 
and thereby discover novel regulatory mechanisms that control local skeletal pattern 
formation.  
In the second chapter of this dissertation, we describe the development of an 
approach to collect and map the spatial coordinates of PMC positions in vivo to more 
accurately assess local regulatory aspects of PMC positioning. This approach allows for 
the measurement of various properties of PMC spatial configurations in three dimensions, 
including PMC distributions, local inter-PMC spacing, and the relative complexity of 
cellular arrangements in 3-D space using principal component analysis. We next 




the spatial distribution of mRNAs in the PMC population. The addition of gene 
expression information to PMC mapping expands the power of this analytical toolkit, 
enabling the investigation of local gene-regulatory control of PMC patterning with 
single-cell resolution. We are able to gain a thorough understanding of the spatial control 
of gene-expression within PMCs and how it relates to skeletal morphogenesis. 
 In the third chapter, we describe an RNA-Seq-based screen from which several 
candidate ectodermal skeletal patterning cues were identified. The basis of this screen 
was a phenotypic overlap between two known ectoderm-modifying chemicals, SB203580 
(SB) and NiCl2, which have opposing effects on axial specification within the ectoderm, 
but elicit a strikingly similar response from the PMCs. Following both treatments, which 
have been shown to specifically target the ectoderm, PMCs are highly disorganized and 
exhibit extensive, elongated filopodia, leading to the hypothesis that ectodermal cues 
regulating PMC positioning are absent in both treatments. Comparative RNA-sequencing 
following treatment with either NiCl2 or SB identified a relatively small subset of 
mutually downregulated genes, which we hypothesized would include cues that were 
required to normally position PMCs. We restricted the pool of candidates to genes whose 
products are secreted, membrane bound, or are known to participate in cell-cell signaling. 
From these, we targeted six genes with translation-blocking morpholinos and found that 
they are indeed required for normal PMC positioning and skeletal patterning, without 
impacting global biomineralization or ectodermal specification. 
 We proceeded to determine the local skeletal regulatory effects of one candidate, 




skeletogenesis. Mutations at the human SLC26a2/7 locus cause diastrophic dysplasia, a 
type of dwarfism characterized by improper skeletal development, making it a logical 
skeletal patterning candidate to interrogate in the sea urchin embryo. SLC is required to 
transport sulfate ions for the synthesis of sulfated proteoglycans (SPGs), essential 
molecules that are well-known to regulate extracellular signaling ligand stability and 
presentation during development, among numerous other functions. We found that SLC 
is expressed in the ventral ectoderm and is required to generate a ventral-to-dorsal 
gradient of SPGs. Morpholino-mediated knockdown of SLC reduces SPG accumulation, 
abolishing this gradient. By limiting the availability of sulfate to the embryo during 
development, we were able to replicate this effect, and, conversely, by overexpressing 
SLC or increasing available sulfate, we abolished the sulfate gradient by globally 
increasing SPG accumulation. We examined the skeletal effects resulting from each of 
these perturbations and noted that formation of the ventral transverse rods (VTs) in 
particular requires ventral SPGs, and that embryos with elevated global SPGs produce 
extra VT elements. The skeletal effects coincided with PMC-positioning defects, since 
the number of ventral PMCs was significantly decreased by SLC or SPG loss, and 
significantly increased by SLC or SPG gains. Because SPGs are known to function by 
modifying ligand signaling, we assessed the impact of SPG perturbation on the VEGF 
pathway, which regulates PMC migration and biomineralization. We found that 
perturbation of SPGs does in fact induce expression changes in VEGF and its receptor 
VEGFR, and that secondary skeletal elements are similarly affected by perturbing either 




the VEGF pathway does not impact the growth of VTs, suggesting that VT formation is 
regulated by SPGs independently of VEGF signaling. Finally, using pharmacological 
inhibition of VEGFR, we demonstrated for the first time that VEGF signaling is required, 
not only for general biomineralization, but also, late in development, for the specific 
patterning of the secondary aboral rods (ARs), which develop posteriorly. Together, these 
results identify two local patterning cues: the novel cue SLC for primary ventral 
patterning, and VEGF for secondary posterior patterning. 
 In Chapter Four, we assess the contributions of a third skeletal patterning gene, 
LvLOX, to local aspects of skeletal morphogenesis. LOX (lipoxygenase) belongs to a 
family of enzymes that modify arachidonic acid to produce hydroxyeicosatetraenoic acids 
(HETEs) – biologically potent signaling molecules involved in diverse physiological 
contexts. LOX was identified in the screen described in Chapter Three. We functionally 
characterized LvLOX as a 5-lipoxygenase that produced 5(S)-HETE. We show that 
LvLOX is initially expressed in the ventrolateral posterior ectoderm, then later expands 
to the ventral posterior ectoderm. We show that LOX activity is required early for the 
normal alignment of the skeletal halves with respect to the anterior-posterior (AP) 
embryonic axis, as well as subsequently for normal skeleton formation at the bilateral 
midline. We also show that global overexpression of LvLOX, or embryonic exposure to 
its primary product 5(S)-HETE suffices to elicit abnormalities in the dorsal skeletal 
elements, and to perturb bilateral registry of left and right skeletal halves. We proceeded 
to show that, unlike SPG perturbation, LOX perturbation does not impact the primary 




normal distance between PMCs in chains (i.e. in the ring and cords); LOX perturbation 
not only dysregulates inter-PMC spacing, but also results in the formation of gaps within 
the syncytial cables. Since the syncytial cables connect the PMCs and are the site of 
biomineral formation, the effects of LOX perturbation on ventral and dorsal skeletal 
patterning are likely due to inter-PMC spacing abnormalities that lead to syncytial gaps, 
which in turn lead to skeletal malformations. We also show that 5(S)-HETE is sufficient 
to induce PMC chemotaxis in vitro, suggesting a direct mechanism for regulating PMC 
positioning. To identify the impact of LOX perturbation on PMC-specific gene 
expression, we developed a protocol to isolate, live-label and sort PMCs from control and 
LOX-inhibited embryos for single-cell transcriptomic analyses. We identified several 
LOX-dependent PMC subset-specific genes, and mapped their spatial expression 
dynamics s in vivo, with or without LOX perturbation. One gene in particular, pks2, 
exhibited significant increases in both mRNA abundance and the spatial extent of its 
expression domain following LOX perturbation, suggesting that LOX activity produces a 
scaffold protein that is required for pks2 repression. Morpholino-mediated knockdown of 
pks2 severely disrupted PMC function, blocking skeleton formation, and specifically 
blocked PMC migration to the ventral portion of the PMC ring, demonstrating that Pks2 
is required within PMCs for both general biomineralization and for primary ventral PMC 
migration, and indicating that Pks2 is a required component of the PMC patterning 
response repertoire.  
 Together, the results presented in this dissertation provide an increased 




skeletal morphogenetic events are regulated by specific, spatially restricted ectodermal 
cues that, in turn, invoke local subsets of PMCs to express specific genes such as tbx2/3 
and pks2. These genes in turn mediate region-specific PMC migration and 
skeletogenesis. Specifically, we show that during gastrulation, the sulfate transporter SLC 
is required to produce sulfated proteoglycans in the ventral ectoderm, which are required 
to recruit PMCs to the ventral territory and thereby pattern ventral skeletal elements (Fig. 
5.1). During the same temporal window, the PMC-specific gene pks2 is similarly 
required for the ventral accumulation of PMCs (Fig. 5.1). It is unclear if the expression of 
pks2 is dependent on SPGs; this will be an interesting question to pursue in the future. 
Following gastrulation, expression of 5-lipoxygenase (LvLOX) within the ventrolateral 
ectoderm is required to orient the skeletal triradiates, mediate inter-PMC spacing, initiate 
PMC migration out of the ventrolateral clusters, and locally repress the expression of 
pks2. Interestingly, the pattern of pks2 expression at 18 hpf coincides spatially with 
future skeletal branching and termination points, suggesting that pks2 may mark these 
regions for future morphogenetic events (Fig. 5.1), and that LOX is likely instrumental in 
establishing this pattern. In LOX-perturbed embryos, we observe pks2 expression in 
ventrolateral PMCs that corresponds with decreased migration out of the ventrolateral 
clusters, suggesting that pks2 repression may be required for the migration of PMCs out 
of this region (2  migration, Fig. 5.1). VEGF expression in the ventrolateral ectoderm is 
similarly required near the end of gastrulation for the migration of PMCs out of this 
region and for the elongation of the aboral skeletal rods, which form adjacent to its 




expression arises within the ventral ectoderm and is required for the elongation of the 
adjacent ventral skeletal elements (Fig. 5.1). We therefore conclude that skeletal 
patterning is a complex, highly regulated process in which numerous ectodermal cues 
impart "instructions" to PMCs via the induction of their spatially-specific diversification; 
together, these effects choreograph the movement of PMCs and coordinate their synthesis 
of the sea urchin larval endoskeleton. 
5.2 Future Directions 
 The studies presented herein contribute to the evolving story of skeletal pattern 
formation, and the techniques and approaches developed during this research expand both 
the systems-level and cell biological analytical toolkits available for future studies, 
opening new avenues to pursue these and other similar experimental questions. 
 The RNA-seq based screen described in Chapter Three identified hundreds of 
potential skeletal patterning candidates, many of which may play distinct roles in 
regulating PMC patterning and skeletal morphogenesis. Along with SLC26a2/7, the 
candidate BMP5-8 has been more fully characterized as a skeletal patterning cue that 
impacts the left side of the skeleton (Piacentino et al., 2016a), while three of these 
candidates, NFL, ST14, and SVEP have been validated via morpholino targeted 
knockdown (Piacentino et al., 2016b). The resulting morphant skeletal phenotypes 
indicate that each gene is required for distinct aspects of skeletal patterning. 
Understanding the contributions of each of these candidate genes to skeletal patterning 
will provide a more comprehensive picture of the mechanisms by which the skeletal 




 We identified sulfated proteoglycans, 5(S)-HETE, and VEGF as skeletal 
patterning cues, but the detailed mechanisms by which each of these cues signals remains 
unclear. For example, learning how 5(S)-HETE mediates its effects would be of 
significant interest, particularly since our results indicate that 5(S)-HETE uses at least 
two mechanisms of action. Proteomic, phospho-proteomic and metabolomic approaches 
will likely be required to gain a comprehensive understanding of the downstream effects 
of 5(S)-HETE. Similarly, the biochemical impact of ventral SPGs remains unknown, nor 
is their biochemical complexity or identity defined. Strategies that manipulate 
glycosaminoglycan synthesis, sulfation, and other post-translational modifications will 
clarify their identity, particularly in combination with glycan-focused mass spectrometry 
analysis. Finally, it is likely that SPGs are involved in stabilizing and/or presenting 
VEGF ligands, and biochemical and molecular biological approaches to query that 
relationship will potentially illuminate additional functions for SPGs in promoting 
secondary skeletal patterning.  
This research focuses extensively on PMC migration and positioning, and the 
regulation of these processes is multi-faceted. Two of the patterning genes we examine in 
this thesis, LOX and SLC, have presumably different mechanistic underpinnings for their 
regulation of PMC positioning, and while we find that they both attract PMCs and are 
expressed in similar embryonic territories, the PMC phenotypes we observe following 
knockdowns are quite distinct. To better understand these differences, we will employ 
single-cell RNA-seq analysis of PMCs perturbed for each or both of these pathways to 




This approach will ultimately allow the construction of the ectoderm-PMC patterning 
gene regulatory networks. We will combine these studies with migration experiments in 
vitro and in vivo in which we manipulate the ectodermal patterning cue and/or PMC 
subset gene expression, to understand how cues work together with the subset genes to 
mediate each of the subset's migratory and morphogenetic responses.  
We identified a curious phenomenon of the selective transport and gating of 
mRNAs in the syncytial cables that connect the PMCs; this observation is counter to prior 
findings that mRNAs are not trafficked through the cables. To determine if and how 
mRNAs are transferred between PMCs, we will employ noncoding "marker" mRNAs 
that we can readily detect by FISH analysis. We will then generate chimeras of normal 
embryos that contain a transplanted PMC that expresses the marker at a range of levels. If 
the marker RNA is transported, that will conclusively demonstrate that the cables are 
permissive for mRNA trafficking. The transplanted PMC will also express EGFP both to 
mark it, and as a positive control, since protein transport through the syncytial cables 
does occur. If the marker RNA is transported, then we will turn to mutational analysis of 
sequences within tbx2/3, in an effort to identify sequences required for its apparent gating 
at the ring/cluster boundary. It is likely that such sequences are localized within the 
untranslated regions, and in that event, we will confirm their role by fusing those 
sequences to the marker RNA to test whether they suffice to similarly gate trafficking in 
the cable at the ring/cluster boundary.  




 Prior to this thesis, our understanding of the molecular nature of skeletal 
patterning was limited to broad regulators of PMC positioning and biomineralization. 
Here, we have identified ectodermally expressed cues that operate locally to direct the 
migration of the PMCs and thereby pattern specific skeletal elements. We have also 
scrutinized the local properties of the primary mesenchyme cell population that provides 
a more detailed understanding of the intricate processes underlying skeletal 
morphogenesis. In Chapter 2, we develop 3-D modeling techniques to understand how 
PMCs and gene expression patterns within PMCs are spatially organized. We then 
developed an RNA-seq based screen to identify novel skeletal patterning cues, from 
which we validated and functionally analyzed two genes, sulfate transporter SLC26a2/7 
and 5-lipoxygenase. Both of these cues are expressed in the ventral ectoderm during 
skeletogenesis, but their activity has distinct effects on the local PMC population and 
resulting skeletal pattern. By comparing the effects of perturbing each of these pathways, 
we can construct a PMC-based view of the regulation of the morphogenetic events that 
pattern the ventral larval endoskeleton. 
 The studies presented in this thesis are part of a much larger, ongoing research 
effort. Synthesis of the sea urchin larval endoskeleton is an exquisitely reproducible 
process with a wide-range of regulatory inputs, many of which are likely undiscovered. 
Further experiments will be required to understand not just their individual contributions 
to morphogenetic decisions, but also how these contributions are integrated during 
skeletogenesis. Together, these continuing studies will help us understand how particular 




behaviors translate to morphogenetic events that regulate skeletal patterning and, more 








Figure 5.1 A model of morphogenetic events regulated by ectodermal and PMC 
skeletal patterning genes during sea urchin development. Schematics showing 
temporal windows during which ectodermal skeletal patterning genes and PMC-specific 
skeletal patterning genes are expressed and relevant to skeletogenesis (top). The ectoderm 
is shown in grey, PMCs are shown as circles, skeletal rods are shown as black lines. 
Numbers refer to numbered events within each developmental window in the table 
below. Expression territories of SLC (green), LOX (red), VEGF (magenta), and pks2 
(red) and morphogenetic events that are regulated by each gene during the three 
developmental windows are listed (bottom table). Abbreviations: D, dorsal; V, ventral; 
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